Introduction {#s1}
============

The conserved PCP signaling pathway regulates the orientation of cells and organelles within the plane of an epithelium and is crucially important for developmental patterning as well as organ morphogenesis, homeostasis, and physiology ([@bib34]; [@bib48]; [@bib32]; [@bib45]). Pioneering studies in *Drosophila* and *Xenopus* have revealed that global, non-cell autonomous, and cell intrinsic signaling mechanisms act in concert to establish tissue polarity. Core PCP molecules including Van Gogh-like (Vangl1-2), Cadherin EGF LAG seven-pass G-type receptor (Celsr1-3), Frizzled (Fzd3, 6), Dishevelled (Dvl1-3), and Prickle (Pk1-2) are localized asymmetrically at the cell cortex to provide polarity information for morphogenesis and oriented cell division. Significant progress has been made in understanding the asymmetric core PCP localization in vertebrates but it is less clear how this regulates cytoskeletal rearrangements that drive morphogenesis via tissue specific downstream effector molecules ([@bib45]). Thus, the identification of novel PCP effectors that indicate pathway activity and mediate signaling and/or morphogenesis will be the key to unravel the function of this molecular pathway in development and disease.

Besides the Rho family of GTPases, which are also implicated in apical--basal (A--B) polarity establishment, the best-studied PCP effector molecules are Inturned (Intu) and Fuzzy (Fuz) ([@bib4]; [@bib30], [@bib31]; [@bib11]). Both directly regulate ciliogenesis by mediating the assembly of the apical actin cytoskeleton but are not required for the polarized accumulation of core PCP components. The core PCP molecule Dvl2 localizes near the base of cilia and functions together with Intu and Rho GTPases to dock and polarize BBs for cilia formation and directed ciliary beating ([@bib31]). BBs are amplified deep in the cytoplasm of multiciliated cells (MCCs) and apical plasma membrane (PM) transport depends on Dvl and the vesicle trafficking protein Sec8. Up-to-date it is not understood how core PCP molecules physically connect to effector molecules, how this leads to asymmetric membrane polarization and cytoskeletal rearrangements, and if these mechanisms are conserved among different cell types in various organs and during evolution.

First functional evidence for PCP in lung development came from the analysis of Celsr1, Vangl2, and Scribble (Scrib) mutant mice, which showed defects in branching morphogenesis and narrowed lung airways due to cytoskeletal and junctional defects ([@bib50]). Multiciliated lung cells first arise at embryonic day (E) 14.0 in the trachea as well as in the main bronchi ([@bib13]). Similar to the mucociliary epithelium in frog, differentiation depends on BB amplification, docking, and orientation that allows the formation of hundreds of motile cilia. The differentiation of multiciliated lung cells and the dynamics of the underlying cell biological processes can be modeled in air liquid interface (ALI) cultures of primary mouse tracheal epithelial cells (mTECs) ([@bib51]; [@bib44]; [@bib42]). Asymmetric localization of core PCP molecules at apical junctions regulates the orientation of motile cilia along the longitudinal tissue axis for directed beating and mucus clearing. This likely interdepends on non-cell autonomous cues and intrinsic polarized microtubule (MT) network topology ([@bib42]). Currently, PCP effector molecules that link core molecules, BBs, polarized MTs, and the actin cytoskeleton have not been identified. A better understanding of these molecular processes could provide further insight into a multitude of ciliary dysfunction syndromes of the lung and other organs.

The best-established model to study PCP in vertebrates is the organ of Corti in the inner ear (IE). Mechanosensory hair cells (HCs) are arranged in one inner (IHC) and three outer HC (OHC) rows. The lateral polarization of the V-shaped actin-based stereocilia bundles on HCs strongly depends on ciliogenesis and PCP for proper sound perception ([@bib28]; [@bib46], [@bib47]; [@bib15]). Core PCP molecules like Celsr1, Dvl2/3, Fz3/6, and Vangl2 are localized to distinct apical membrane compartments of HCs and supporting cells ([@bib9]). This differential localization seems not sufficient to instruct morphogenesis of actin-rich hair bundles in mammals ([@bib15]). Instead, it depends on opposing localization of evolutionarily conserved spindle positioning and apical polarity proteins that serve as a blueprint for kinocilium migration and bundle formation ([@bib8]; [@bib40]). It remains unclear, how core PCP molecules couple to spindle positioning complexes and the actin cytoskeleton to orchestrate morphogenesis.

Spindle positioning proteins as well as the actin and MT cytoskeleton act together with cues from the cell cortex, such as apical junctions and polarity proteins to direct spindle positioning in mammalian epithelial cells ([@bib19]). In addition to Inscuteable (mInsc in mammals), Partner of Inscuteable (mPins/LGN in mammals) and the G-protein coupled receptor Gα~I~ and other evolutionary conserved proteins, such as the basolateral determinants and septate junction localized proteins Dlg and Scrib, regulate A--B spindle positioning ([@bib17]; [@bib36]). In mammals, five *Dlgs* have been identified and we have recently shown that their function has diverged during evolution ([@bib41]). Interestingly, Dlg3 is the only family member that is involved in apical transport and required for tight junction (TJ) consolidation. Taken together, the function of *Drosophila* Dlg in spindle positioning ([@bib1]; [@bib14]; [@bib2]) and mammalian Dlg3 in PCP establishment ([@bib41]), suggested to us that Dlg3 could mediate PCP-dependent BB positioning.

In this study, we identified *Fltp* as a gene expressed in regions of active PCP signaling including the node, the MCCs of the lung, and the sensory hair cells of the inner ear. Knock-out analysis revealed that Fltp is required for BB docking and cilia formation in the lung as well as BB and kinocilium positioning in the IE. Using ALI cultures, we show that *Fltp* expression is induced while BBs are amplified and docked at the apical PM in differentiating MCCs. Fltp localizes next to BBs, and MT plus ends in the apical actin network and is required for efficient BB docking and cilia formation. We provide evidence that Dlg3 functions together with Fltp to position BBs and kinocilia in the inner ear. Dlg3 and Fltp physically interact with each other, the core PCP protein Dvl2, and the pericentriolar matrix protein γ-Tubulin, suggesting that we have identified a novel BB positioning complex in the inner ear. Together, our data implicate that Fltp is a novel regulator important for BB docking and positioning in mono- and multiciliated cell types that acquire PCP.

Results {#s2}
=======

Identification of *Fltp* as a Foxa2 target gene {#s2-1}
-----------------------------------------------

We discovered *Fltp* as a functionally non-annotated gene (*1700009P17RiK*) in a screen to identify Foxa2 target genes involved in polarity establishment ([@bib3]) and expressed in monociliated node cells ([@bib39]; [@bib16]). The enrichment of the transcription factor FOXA2 on conserved binding sites in the promoter region of the human *FLTP* ortholog (*C1Orf192*), suggests that *FLTP* is a direct target of FOXA2 ([Figure 1A](#fig1){ref-type="fig"}) ([@bib49]). The murine *Fltp* gene consists of six exons and the spliced mRNA codes for an open-reading frame (ORF) of 567 nucleotides that translates into a protein of 189 amino acids ([Figure 1B,C](#fig1){ref-type="fig"}). An alignment of the proteins of different species reveals a high conservation during evolution as well as an N-terminal SH3 binding domain and a C-terminal proline-rich repeat (PRR) ([Figure 1C](#fig1){ref-type="fig"}). Interestingly, the mouse *1700009P17RiK* cDNA was also identified in a screen for mRNAs highly abundant in ciliated tissues ([@bib25]).10.7554/eLife.03842.003Figure 1.*FLTP* has active *FOXA2* binding sites in its promoter and is conserved among species.(**A**) A high amount of the endodermal transcription factor FOXA2 binds the human *FLTP* promoter in pancreatic progenitors and in adult islets, indicating that *FLTP* is a direct target of FOXA2 and expressed in these cells. (**B**) *Fltp* shows predicted (Genomatix) Foxj1, Foxa1, and Foxa2 binding sites in its promoter (clear red boxes: exons (E1--E6); yellow box: promoter; TSS: transcriptional start site; light blue boxes: Foxj1, Foxa1, Foxa2 binding sites). (**C**) Fltp protein alignment shows high conservation between different species (highest conservation in the first 76 amino acids). The mouse and human proteins are highly homologous (yellow box: SH3 binding domain; green box: predicted proline rich repeat (PRR); red filled box: peptide sequence of the Fltp116-1 epitope; red empty box: peptide sequence of the Fltp1 epitope; dark blue indicates conservation over 80%; lighter colors indicate less conservation).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.003](10.7554/eLife.03842.003)10.7554/eLife.03842.004Figure 1---source data 1.Mendelian ratio of Fltp intercrosses on different backgrounds.(**A**--**C**) Fltp animals are born roughly at the expected Mendelian ratio in C57Bl6/6NCrl, 129S6/SvEvTac, or CD1 background. Note: *Fltp*^*ZV/ZV*^ animals are slightly underrepresented on the C57Bl6 and 129S6 background.**DOI:** [http://dx.doi.org/10.7554/eLife.03842.004](10.7554/eLife.03842.004)10.7554/eLife.03842.005Figure 1---figure supplement 1.Fltp antibody specificity.(**A**) Western blot of Strep Flag (SF) Tag, Fltp SF-tagged transiently transfected HEK293T cells and testis lysate of *Fltp*^*+/+*^, *Fltp*^*ZV/+*^, and *Fltp*^*ZV/ZV*^ animals incubated with Fltp116-1 antibody. Note, Fltp1 ([Figure 1---figure supplement 2D](#fig1s2){ref-type="fig"}) detects one specific and Fltp116-1 two bands at approximately the calculated size of Fltp, likely representing post-translationally modified Fltp protein. Anti-alpha-Tubulin antibody was subsequently used on the same blot to confirm equal loading. (**B**--**D**) Laser scanning microscopy (LSM) of HEK293T cells transiently transfected with a vector encoding for Fltp-Venus (**B**--**B″**), Venus (**C**--**C′**), and an untransfected control (**D**) stained with Fltp1 and GFP (for Venus). Fltp-Venus can be detected in the cytoplasm by both antibodies. (**E**--**G**) LSM of HEK293T cells transiently transfected with a vector encoding for Fltp-Venus (**E**--**E″**), Venus (**F**--**F′**), and an untransfected control (**G**) stained with Fltp116-1 and GFP. Fltp-Venus can be detected in the cytoplasm by both antibodies. Scale bars; 5 µm (**C**--**G**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.005](10.7554/eLife.03842.005)10.7554/eLife.03842.006Figure 1---figure supplement 2.Fltp construct and confirmation of the knock-out strategy.(**A**) The Fltp^ZV^ targeting strategy deletes the entire open reading frame (ORF) from exon 2 to 6 (exons: black and orange boxes; orange boxes: ORF, primers for genotyping: 418, 420, 565, 566; for primer sequences see Supplemental 'Materials and methods'). The external 5′- as well as the 3′-probe are indicated. Restriction enzyme sites for *DraIII* and *EcoRV* are shown. Homology regions for recombination of the targeting construct are indicated as 5′- and 3′-Retrieval. The figure is on scale (NLS-LacZ: nuclear localization signal-beta-galactosidase; 2A: viral T2A sequence; H2B: histon-2B; Venus: yellow fluorescent reporter gene; SV40-pA: Simian Virus 40 polyadenylation signal; loxP: site of Cre-mediated recombination; bGHpA: bovine Growth Hormone polyadenylation signal; neo: neomycin resistance cassette; PGK: phospho-glycerate kinase; UTR: untranslated region). (**B**) Southern blot of *Fltp*^*+/+*^ embryonic stem (ES) cells vs *Fltp*^*ZV/+*^ ES cells digested with *DraIII* and hybridized with the external 5′ Southern probe showing the Bl6 (16,443 bp), 129 *WT* allele, and the Bl6 targeted allele (11,469 bp). Notice the shift of the *WT* band due to restriction length polymorphism. (**C**) Genotyping PCR to discriminate between *Fltp*^*+/+*^, *Fltp*^*ZV/+*^, and *Fltp*^*ZV/ZV*^ (primers: 418, 565, 566; WT band (317 bp); targeted Δneo band (387 bp)). (**D**) Western blot of testis lysate of *Fltp*^*+/+*^, *Fltp*^*ZV/+*^, and *Fltp*^*ZV/ZV*^ animals incubated with Fltp1 antibody. Fltp protein band is detectable at around 25 kDa (calculated weight 20 kDa). Fltp protein is absent in *Fltp*^*ZV/ZV*^ lysate. The asterisk marks an unspecific band.**DOI:** [http://dx.doi.org/10.7554/eLife.03842.006](10.7554/eLife.03842.006)

To analyze the Fltp protein in more detail, we raised two polyclonal rabbit antibodies against a central and a C-terminal epitope ([Figure 1C](#fig1){ref-type="fig"}). We confirmed the specificity of these antibodies in western blot analysis and immunocytochemistry in transiently transfected HEK293T cells ([Figures 1---figure supplement 1A--G, 2D](#fig1s1 fig1s2){ref-type="fig"}). Endogenous Fltp protein localizes to the apical PM, the BB, and the primary cilium in monociliated mouse node cells, suggestive for a function of Fltp in BB transport, positioning, and/or ciliogenesis ([Figure 2F,G](#fig2){ref-type="fig"}).10.7554/eLife.03842.007Figure 2.Fltp reporter and protein is detectable in mono- and multiciliated tissues.(**A** and **B**) mRNA (Fltp in situ hybridization) (**A**) and *lacZ* reporter expression (**B**) are restricted to the node (n) at E7.5. (**C**--**E**)Whole-mount lacZ stained and benzyl alcohol/benzyl benzoate (BABB) cleared *Fltp*^*ZV/+*^ embryo and organs. (**C**) E11.5 embryo reveals reporter expression in the choroid plexi (cp), prechordal plate (pcp), eye (e), and floor plate (fp). (**D**) E17.5 IE shows reporter expression in posterior crista ampullaris (pca), lateral crista ampullaris (lca), anterior crista ampullaris (aca), utricular macula (uma), and saccular macula (sma) of the vestibular part as well as in the organ of Corti (oc). (**E**) E17.5 lung shows lacZ reporter activity in multiciliated lung epithelial cells. (**F** and **G**) Whole-mount antibody stained embryo (node, E7.75) analyzed by LSM reveals Fltp protein in vesicular fashion in the cytoplasm and along primary cilia (white arrow heads). (**H**--**I′**) Immunohistochemistry on cryosections combined with LSM analysis reveals Fltp at the apical plasma membrane and at cilia in multiciliated lung epithelial cells of *Fltp*^*+/+*^adult animals (**H** and **H′**). No Fltp immunoreactivity is detected in *Fltp*^*ZV/ZV*^ lungs (**I** and **I′**). ZO-1 marks apical TJs, α-Tubulin (alpha Tub), and acetylated-Tubulin (aT), the tubulin network and cilia; nuclei are marked by DAPI and Fltp by Fltp1 (**F** and **G**) and Fltp116-1 (**H**--**I′**). Scale bars; 100 µm (**A** and **B**), 500 µm (**C**, **D**, **E**), 10 µm (**F**), 4 µm (**G**), and 10 µm (**H**--**I′**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.007](10.7554/eLife.03842.007)10.7554/eLife.03842.008Figure 2---figure supplement 1.Additional *Fltp* reporter expression in mono- and multiciliated tissues.(**A**--**H**) Whole-mount lacZ stained and benzyl alcohol/benzyl benzoate (BABB) cleared (**D**, **F**, **H**) *Fltp*^*ZV/+*^ embryos and organs. β-gal activity is restricted to the node (n) (**A**). (**B**) Cross-section of the neural tube (dotted line) reveals reporter expression in the floor plate (fp). (**C**) Reporter expression can be detected in the four choroid plexi (cp), the fp, and the inner ear (ie). (**D**) *lacZ* expression analysis reveals β-gal activity in the developing cp of the first, second, third, and fourth ventricle, in the prechordal plate (pcp), in the developing eye (e), and in the fp. (**E** and **F**) *LacZ* reporter is expressed in the 6 sensory regions of the IE. Onset of reporter expression is at E12.5. (**G** and **H**) LacZ staining of whole-mount lungs shows onset of reporter expression in the main stem bronchi at E14.5 (**G**). Later, expression is restricted to the lung epithelium (**H**). (**I**) Histological section through a lacZ stained adult lung showing β-gal activity in the lung epithelium. (**J**) Laser scanning microscopy of lung cryosections reveals *Fltp* reporter expression in epithelial lung cells. Expression directly stops at the broncho-alveolar-duct junction (BADJ). The alveoli are absent of *Fltp* reporter staining. Fltp reporter positive cells are marked by GFP and nuclei by DAPI. Scale bars; 200 µm (**A**), 250 µm (**B**), 500 µm (**C**--**H**), 150 µm (**I**), 75 µm (**J**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.008](10.7554/eLife.03842.008)

*Fltp* is expressed in mono- and multiciliated tissues during PCP acquisition {#s2-2}
-----------------------------------------------------------------------------

To explore *Fltp* expression and function in vivo, we generated an *Fltp*^*ZV*^ knock-in/knock-out allele by replacing the entire ORF by a multicistronic lac[Z]{.ul}-[V]{.ul}enus reporter cassette ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"} and Supplemental 'Materials and methods'). PCR genotyping as well as Southern and western blotting analysis confirmed the targeted homologous recombination and the generation of a null allele ([Figure 1---figure supplement 2B--D](#fig1s2){ref-type="fig"}). *Fltp* homozygous knock-out mice are born at roughly the expected Mendelian ratio and are viable and fertile on CD1, C57BL/6NCrl and 129S6/SvEvTac background ([Figure 1---source data 1](#SD1-data){ref-type="supplementary-material"}).

Next, we characterized the temporal and spatial expression pattern of the *Fltp* reporter during embryonic development. LacZ reporter activity in *Fltp*^*ZV/+*^ animals is first detectable in the embryonic node at E7.5 ([Figure 2B](#fig2){ref-type="fig"}), which accurately reflects endogenous mRNA expression ([Figure 2A](#fig2){ref-type="fig"}) and confirmed our previous findings ([@bib39]; [@bib20]). At E8.5--13.5, strong reporter activity is detected in the eye, notochord, floor plate of the neural tube, and all four choroid plexi ([Figure 2C](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1A--D](#fig2s1){ref-type="fig"}), tissues that are either mono- or multiciliated and depend on active PCP signaling. Consistent with a potential function in the PCP pathway, *LacZ* reporter activity in the IE coincides with BB docking and kinocilium positioning at E13.5 ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}) ([@bib26]; [@bib9]). The *Fltp* reporter remains expressed during development and early postnatal life in all six sensory regions of the IE ([Figure 2D](#fig2){ref-type="fig"}, [Figure 5A](#fig5){ref-type="fig"}, [Figure 2---figure supplement 1C,E,F](#fig2s1){ref-type="fig"}). Furthermore, *Fltp* reporter activity strongly correlates with the spatial and temporal onset of ciliogenesis in the lung trachea and the main bronchi at E14.5--17.5 ([Figure 2E](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1G,H](#fig2s1){ref-type="fig"}). In adult lungs at postnatal day (P) 30, the dual *lacZ* and *H2B-Venus* reporter remains expressed in MCCs of the bronchioles, but not in non-ciliated cells of the alveoli ([Figure 2---figure supplement 1I,J](#fig2s1){ref-type="fig"}). To confirm the reporter studies, we analyzed cell type-specific and subcellular localization of the endogenous Fltp protein in the embryonic node and adult lung epithelium. Whole-mount antibody staining combined with laser scanning microscopy (LSM) on gastrula-stage embryos revealed that the Fltp protein is localized at the apical PM, TJs, primary cilia, and in the cytoplasm of node cells ([Figure 2F,G](#fig2){ref-type="fig"}). Immunohistochemistry on lung sections further shows that Fltp is highly enriched at the apical cortex and in cilia of the multiciliated bronchial epithelial cells ([Figure 2H,Hʹ](#fig2){ref-type="fig"}). The absence of Fltp immunoreactivity in *Fltp*^*ZV/ZV*^ lung sections further confirmed antibody specificity ([Figure 2I,Iʹ](#fig2){ref-type="fig"}). Taken together, *Fltp* reporter and endogenous expression accurately correlate with onset of PCP establishment in the embryonic node, floor plate, choroid plexi, IE, and lung, which is indicative for a function in or downstream of the PCP pathway.

Fltp regulates BB docking and cilia formation in multiciliated lung cells {#s2-3}
-------------------------------------------------------------------------

The embryonic and adult lung depends on PCP signaling for branching morphogenesis, BB docking, and cilia formation ([@bib50]; [@bib42]). First, we investigated the highly stereotypic branching pattern in cleared lacZ stained lungs at P60 ([@bib27]). No difference was detectable in *Fltp*^*T2AiCre/+*^; *R26*^*R/+*^(Gt\[ROSA\]26Sor) controls lungs with normal levels of Fltp protein ([@bib37]; [@bib20]), *Fltp*^*ZV/+*^ heterozygous and *Fltp*^*ZV/ZV*^ homozygous mutant lungs, indicating that Fltp has no function during branching morphogenesis ([Figure 2E](#fig2){ref-type="fig"}, [Figure 3A--C](#fig3){ref-type="fig"}). In contrast, measurement and quantification of terminal lung bronchiole diameters revealed a dose-dependent and statistically significant constriction of the distal airways ([Figure 3A--D](#fig3){ref-type="fig"}), suggesting that normal Fltp levels are important for lung airway homeostasis. To better understand the etiology of the airway constrictions, we analyzed *Fltp* expression and function on cellular level in *Fltp*^*+/+*^, *Fltp*^*ZV/+*^, and *Fltp*^*ZV/ZV*^ adult lungs at P7 and P30 ([Figure 3E--L](#fig3){ref-type="fig"}). *Fltp-driven H2B-Venus* reporter activity was confined to the nuclei of multiciliated epithelial cells in *Fltp*^*ZV/+*^ and *Fltp*^*ZV/ZV*^ lungs at P7 and P30. LSM analysis further confirmed that cilia formation was significantly affected in a dose-dependent fashion ([Figure 3E--L](#fig3){ref-type="fig"}), similar to PCP effector knock-down phenotypes in the mucociliary epithelium of *Xenopus laevis* ([@bib30], [@bib31]).10.7554/eLife.03842.009Figure 3.Loss of *Fltp* leads to constricted distal airways and cilia formation defects in the lung.(**A**--**C**) Whole-mount lacZ stained and BABB cleared distal airways of left lung lobes at P60. Red lines show how diameters were measured. (**A**) *Fltp*^*T2AiCre/+*^; *R26*^*R/+*^is used as *control* (*Ctrl*). (**B** and **C**) *Fltp*^*ZV/+*^ and *Fltp*^*ZV/ZV*^ animals show constricted distal airways. (**D**) Average distal airway diameter of *Ctrl* animals is 132.25 µm (n = 4; 125 bronchi), of *Fltp*^*ZV/+*^ animals is 99.68 µm (n = 3; 90), and of *Fltp*^*ZV/ZV*^ animals is 90.06 µm (n = 3; 95). (**E**--**G** and **I**--**K**) Immunohistochemistry on cryosections of lung distal airway epithelium combined with LSM analysis. (**E** and **I**) In *Fltp*^*+/+*^animals BBs project cilia at the apical surface. (**F** and **J**) In *Fltp*^*ZV/+*^ animals less and shorter cilia are detectable. (**G** and **K**) *Fltp*^*ZV/ZV*^ animals often show absence of or shorter cilia at the apical surface. Note that only very few BBs are docked at the apical surface. (**H** and **L**) *Fltp*^*ZV/ZV*^ animals show significant shorter cilia than *Fltp*^*+/+*^ animals. In total we examined n = 3 (81 cells) for *Fltp*^*+/+*^, n = 2 (22) for *Fltp*^*ZV/+*^, and n = 2 (93) for *Fltp*^*ZV/ZV*^ P7 animals. For P30 we examined n = 3 (121 cells) for *Fltp*^*+/+*^, n = 3 (134) for *Fltp*^*ZV/+*^, and n = 2 (138) for *Fltp*^*ZV/ZV*^. BBs are marked by γ-Tubulin (γTub), cilia by acetylated-Tubulin (aT), cell membrane by β-Catenin (βCat), nuclei by DAPI, and nuclei of *Fltp* reporter expressing cells by GFP. Statistical analysis uses an one way ANOVA (\*\*p = 0.0028; \*\*\*p \< 0.0001 for (**D**) and \*p = 0.0143; \*\*p = 0.0025 for (**H** and **L**)). Error bars show the 95% confidence interval of the mean (**D**) and the standard error of the mean (**H** and **L**). Scale bars; 200 µm (**A**--**C**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.009](10.7554/eLife.03842.009)

To analyze the dynamic cellular and molecular requirement for Fltp during BB docking, cilia formation, and PCP establishment, we employed the mTEC culture system ([@bib51]; [@bib42]). Switching mTEC culture to ALI conditions induces a differentiation process of lung progenitor cells towards a MCC phenotype. During differentiation the progenitor cells pass through different maturation stages ([Figure 4A](#fig4){ref-type="fig"}): Monociliated lung progenitor cells (stage I) start centrosome/BB amplification followed by BB transport and docking (stage II--III) and subsequent cilia formation (stage IV) ([@bib42]). In these cultures, Fltp-driven H2B-Venus reporter activity is activated at the transition from stage I to stage II when centrosomes/BBs are amplified and docked in heterozygous and homozygous Fltp ALI cultures ([Figure 4B](#fig4){ref-type="fig"}). *Fltp-H2B-Venus* expression increases during maturation until cells are terminally differentiated. This correlates with active PCP signaling and initial asymmetric core component localization ([@bib42]). Subcellular co-localization studies further revealed that Fltp is localized to the apical, but not sub-apical actin cytoskeleton and fills the gaps in the actin network from where MT-based cilia project ([Figure 4C--Cʹʹʹ,E](#fig4){ref-type="fig"}). Moreover, Fltp co-localizes with newly synthesized MT plus ends that are labeled with anti-EB1 antibodies ([Figure 4D](#fig4){ref-type="fig"}). Together with the direct adjacent localization of Fltp next to the pericentriolar matrix stained by γ-Tubulin ([Figure 4E](#fig4){ref-type="fig"}), these data suggest that Fltp connects BBs and ciliary MT plus ends to the cortical actin cytoskeleton. To test this idea, we examined mTECs switched to ALI conditions from *Fltp*^*+/+*^ and *Fltp*^*ZV/ZV*^ mice at day two and four of differentiation qualitatively and quantitatively. *Fltp*^*+/+*^ and *Fltp*^*ZV/ZV*^ differentiated with comparable efficiencies and speed as measured by Fltp-driven *H2B-GFP* expression and centrosome amplification ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}), and a comparable number of centrosomes are formed in differentiating *Fltp*^*+/+*^ and *Fltp*^*ZV/ZV*^ mTECs ([Figure 4F,G](#fig4){ref-type="fig"}), whereas BB docking and cilia formation was delayed at ALI+2 and +4 days of differentiation ([Figure 4F--I](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). Taken together, these data suggest that Fltp functions in the process of BB docking and cilia formation.10.7554/eLife.03842.010Figure 4.Fltp is expressed and necessary during BB docking.(**A**) Scheme of multiciliated cell (MCC) maturation. A MCC progenitor projects a primary cilium at the apical surface (stage I). Centrosome amplification is the first sign of differentiation (stage II) followed by apical transport and docking of BBs (stage III). Fully differentiated cells project multiple motile cilia at the apical surface (stage IV). Staging according to [@bib44]. The green nucleus indicates *Fltp* reporter gene expression. (**B**--**G**) LSM of ALI culture of *Fltp*^*ZV*^ and *WT* mTECs. (**B**) Onset and level of *Fltp* reporter expression correlate with the onset of BB amplification and ciliogenesis (stage II--IV) in cultured ALI mTECs as shown in the scheme in (**A**). (**C**--**C′′′**) Confocal sections of a single cell from the sub-apical actin level (**C**) over the apical actin level (**C′** and **C″**) to the cilia level (**C′′′**) (ALI day 4). Fltp co-localizes with the MT-plus end binding protein EB-1 (**D**) (ALI day 4) next to the pericentriolar matrix (**E**) (ALI day 4) and to cilia in multiciliated *Fltp*^*+/+*^ cells (**C′′′**). (**F**) *Fltp*^*+/+*^ cell showing all BBs (red dots) projecting cilia (white stripes) at the apical surface (ALI day 4). (**G**) In many *Fltp*^*ZV/ZV*^ cells the majority of BBs are not docked at the level of tight junctions marked by ZO-1 and do not project cilia (ALI day 4). (**H** and **I**) Side view IMARIS surface rendering shows that all BBs are docked at the apical surface in *Fltp*^*+/+*^ (**H**) (ALI day 4) in contrast to *Fltp*^*ZV/ZV*^ cells where most BBs stay in the cytoplasm (**I**) (ALI day 4). BBs are marked by γ-Tubulin (γTub) and pericentrin (Peric), cilia and the tubulin network by tyrosinated-Tubulin (Tyr Tub) and acetylated-Tubulin (aT), the actin network by Phalloidin (Phall), MT plus ends by EB-1, Fltp protein by Fltp116-1, nuclei by DAPI, and nuclei of *Fltp* reporter expressing cells by GFP. Scale bars; 2 µm (**C**--**C′′′**, **D**, **E**), 5 µm (**F** and **G**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.010](10.7554/eLife.03842.010)10.7554/eLife.03842.011Figure 4---figure supplement 1.ALI differentiation efficiency and quantification of BB docking defect.(**A**) Graph showing the percentage of cells in stage II--IV for *WT* and *Fltp*^*ZV/ZV*^ (*HOM*) ALIs at day zero (before the switch to ALI condition), one, two, and four measured by GFP and pericentrin (*HOM*) and only pericentrin (*WT*) staining compared to the total amount of cells in the ALI culture stained by DAPI (representative images were analyzed). For *WT* analysis we counted n = 1 (1493 cells) for day 0, n = 1 (1345) for day 1, n = 2 (1635) for day 2, n = 2 (1262) for day 4 and for *HOM* n = 1 (1367 cells) for day 0, n = 1 (1542) for day 1, n = 3 (942) for day 2, n = 4 (1123) for day 4. (**B**) Shows the percentage of ciliation (measured by acetylated-Tubulin staining) of cells with amplified centrosomes (measured by pericentrin staining) for *WT* and *HOM* ALIs at day two and four categorized into stage II--III and stage IV. For *WT* analysis we counted n = 4 (609 cells) for day 2, n = 4 (231) for day 4 and for *HOM* n = 10 (611) for day 2, n = 7 (286) for day 4.**DOI:** [http://dx.doi.org/10.7554/eLife.03842.011](10.7554/eLife.03842.011)

Fltp regulates kinocilium positioning and stereocilia bundle morphogenesis in the inner ear {#s2-4}
-------------------------------------------------------------------------------------------

To analyze the function of Fltp in PCP, BB positioning, and cilia formation in vivo, we employed the best-characterized mammalian PCP model system, the organ of Corti in the IE. Morphologically the IE looked normal and the cochlear duct is not significantly shortened or widened in *Fltp*^*ZV/+*^ and *Fltp*^*ZV/ZV*^ mice, indicating that PCP-mediated convergent extension movements are not affected at P0 (data not shown). However, significant deviations of the polarized arrangement of stereocilia bundles can be seen in IHC and OHC rows with increasing severity closer to the apex along the apico-basal axis ([Figure 5B--C,J--N](#fig5){ref-type="fig"}). In addition, scanning electron microscopy (SEM) analysis uncovered severe stereocilia bundle morphogenesis defects and mispositioning of the MT-based kinocilium, very similar to phenotypes observed in mutants of spindle positioning proteins, such as Gα~i3~, mPins, mInsc, and LGN ([Figure 5D--I](#fig5){ref-type="fig"}) ([@bib8]; [@bib40]).10.7554/eLife.03842.012Figure 5.*Fltp* is required for kinocilium positioning and stereocilia bundle formation.(**A**) Whole-mount LSM of an *Fltp*^*ZV/+*^ organ of Corti (OC) showing its different regions. *Fltp* reporter expression is restricted to all sensory HCs (IHC and OHC) of the OC (red dashed line). (**B**--**M**) Whole-mount SEM pictures of an E18.5 OC. (**B** and **C**) *Fltp*^*+/+*^ (*WT*) HCs at 50% of the OC length are perfectly polarized (**B**) whereas *Fltp*^*ZV/ZV*^ (*HOM*) HCs show orientational defects (**C**). (**D**--**I**) Enlargements of HCs reveal perfect polarized kinocilia as well as highly ordered stereocilia in *WT* (**D**). *HOM* cells are misaligned and show split stereocilia bundles (**E**, **G**--**I**), general bundle morphology defects (**E**--**I**), as well as detached kinocilia (**E**). Polarity and stereocilia bundles disruption increases in *HOM* hair cells from 75% (**K**) to \>75% (**M**) of OC length compared to *WT* cells (**J** and **L**). (**N**) Deviation of HCs from the polarity axis for *WT* and *HOM* animals significantly differs in all OC regions (\<50%, 50%, 75%, \>75%). Quantification of HC rotation was performed by measuring the angle from the normal tissue polarity (measured by the medial to distal alignment of the HC rows) to the middle of the stereocilia bundle. In total we examined n = 4 (219 HCs) of *WT* and n = 7 (426) of *HOM* animals. Statistical analysis uses circular statistics (\*\*\*\*p \< 0.0001). Error bars show the standard deviation. Kinocilia are marked by the red dashed lines, nuclei by DAPI, and nuclei of *Fltp* reporter expressing cells by GFP. Abbreviations: inner hair cell (IHC), outer hair cell (OHC1-3). Scale bars; 10 µm (**B** and **C**), 1 µm (**D**--**I**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.012](10.7554/eLife.03842.012)

To seek first evidence if Fltp functions in the PCP pathway, we investigated a potential genetic interaction of *Fltp* with the core PCP component *Celsr1* ([@bib5]). As *Fltp* and *Celsr1* are co-expressed in the cochlea of the IE ([@bib35]), we compared stereocilia bundle morphogenesis in *Celsr1*^*crsh/crsh*^ single mutant and *Fltp*^*ZV/ZV*^; *Celsr1*^*crsh/crsh*^ double mutant cochleae at E18.5. On the mixed genetic background analyzed, *Celsr1*^*crsh/crsh*^ animals showed rather normal bundle alignment in IHCs and OHCs from the base to the middle part of the cochlea (\<50%), but the alignment was significantly disturbed closer to the apex (\>50%) ([Figure 6A,C,D](#fig6){ref-type="fig"}). In contrast, *Fltp*^*ZV/ZV*^; *Celsr1*^*crsh/crsh*^ double mutant cochleae revealed an increased degree of misaligned stereocilia bundles, most pronounced in the \<50% region, and showed an additional fourth OHC row ([Figure 6B--D](#fig6){ref-type="fig"}). These data suggest that *Fltp* and the core PCP gene *Celsr1* either act together in the PCP pathway or in two parallel pathways important for the morphogenesis of the cochlea. To clarify if Fltp is necessary to establish PCP in the IE according to the current model ([Figure 6E](#fig6){ref-type="fig"}) ([@bib9]), we further investigated the localization of core PCP components. No differences in the asymmetric distribution of Vangl1 and Dvl2 at the cell cortex along the medio-lateral axis were detected in *Fltp*^*+/+*^and *Fltp*^*ZV/ZV*^ cochleae at E18.5 ([Figure 6F--I](#fig6){ref-type="fig"}), consistent with a function of Fltp downstream of core PCP molecules.10.7554/eLife.03842.013Figure 6.*Fltp* is a potential downstream mediator of PCP signaling.(**A**--**B**) LSM of an E18.5 *Fltp*^*+/+*^*; Celsr1*^*crsh/crsh*^ (*WT*) organ of Corti (OC) (**A**) revealed rotated outer (OHC) and inner hair cells (IHC). *Fltp*^*ZV/ZV*^*; Celsr1*^*crsh/crsh*^ (*HOM*) OC (**B**) shows more severely rotated IHCs and OHCs as well as an additional OHC row in comparison to (**A**). (**C** and **D**) Hair cells of *HOM* (red) animals show a more pronounced PCP phenotype compared to *WT* (blue) in the region \<50% and \>50% of the OC (for cochlea region nomenclature and quantification method see [Figure 5](#fig5){ref-type="fig"}). In total we analyzed n = 1 (130 cells) at \<50%, n = 1 (90) at \>50% for *WT*, n = 5 (298) at \<50%, n = 5 (743) at \>50% for *HOM*. Statistical analysis uses a Kruskal--Wallis test (\*p = 0.0375; \*\*\*p = 0.0003). Error bars show the 95% confidence interval of the mean. (**E**) Model illustrating PCP molecule localization in IE hair cells. (**F**--**I**) Whole-mount IE (E18.5) LSM of 3 OHC rows revealed Vangl1 localization at the lateral side of supporting cells in *Fltp*^*+/+*^ (**F**) and *Fltp*^*ZV/ZV*^ (**G**) animals and Dvl2 localization at the lateral side of IE hair cells in *Fltp*^*+/+*^ (**H**) and *Fltp*^*ZV/ZV*^ (**I**) animals indicating that core PCP protein localization is not disrupted. The actin network and stereocilia are marked by Phalloidin (Phall) and core PCP proteins by Vangl1 and Dvl2. Abbreviations: inner phalangeal cells (PhC), inner pillar cells (IPC), outer pillar cells (OPC), Deiters\' cells (DC1-3). Scale bars; 10 µm (**A** and **B**), 5 µm (**F**--**I**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.013](10.7554/eLife.03842.013)

Dlg3 and Fltp regulate BB positioning in the inner ear {#s2-5}
------------------------------------------------------

BB positioning and stereocilia bundle morphogenesis depend on spindle positioning proteins ([@bib8]; [@bib40]), but how these connect to core PCP molecules and actin-rich stereocilia bundles is unknown. Due to PCP defects in the IE ([@bib41]), we hypothesized that the mammalian scaffold protein Dlg3 might be a cortical adaptor for PCP-mediated BB positioning. Due to the lack of good antibodies and tools, we generated a transgenic mouse line that constitutively expresses a Venus fluorescent protein fused to the N-terminus of Dlg3 (Dlg3-Venus) (see Supplemental 'Materials and methods'). Next, we examined the subcellular localization of the Dlg3-Venus fusion protein in relation to BB, kinocilium, stereocilia bundle, core PCP molecules, and TJs in cochlea HCs using LSM and three-dimensional reconstruction ([Figure 7A--Bʹ,F--H](#fig7){ref-type="fig"}). Dlg3 specifically localizes in a crescent shape to the bare zone around the BB and co-localizes with the core PCP component Dvl2 at lateral TJs ([Figure 7A--Bʹ,G](#fig7){ref-type="fig"}), the area where mPins/LGN, mInsc, and Gα~i~ are localized ([@bib8]; [@bib40]). This suggests that Dlg3 might have a conserved function in spindle/BB positioning ([@bib14]). Interestingly, Fltp localizes at the interface between Dlg3 and the actin-based stereocilia bundles ([Figure 7C--Eʹ](#fig7){ref-type="fig"}), further suggesting that Fltp might be an adaptor protein linking spindle/BB positioning proteins to the apical actin cortex.10.7554/eLife.03842.014Figure 7.Fltp is located at the interface of apical actin and Dlg3 in IE hair cells.(**A**, **B**, **C**--**D′**, **F**--**H**) Single section LSM of outer HCs of an *Fltp*^*+/+*^*; Dlg3-Venus* animal at E18.5 reveals that Dlg3-Venus is located at the lateral membrane and at the medial membrane (or the lateral membrane of the supporting cell) of IE HCs (**A** and **B**). Fltp is localized lateral to the cuticular plate (CP) and the stereocilia bundles (SC) (**C** and **D**). Dlg3-Venus is located in a lateral crescent overlapping with Fltp localization (**C′** and **D′**). The unstained area marks the region of the BB (**C′** and **D′**). Dlg3-Venus is co-localized with Dvl2 (**G**) at the most lateral membrane directly opposite of Vangl1 (**F**) and with ZO-1 at the apical membrane (**H**). (**A′**, **B′**, **E**, **E′**) IMARIS wireframe animation of a *Dlg3-Venus* IE HC showing Dlg3-Venus co-localization with the BB, the kinocilium, and actin (**A′** and **B′**) and a *Fltp*^*+/+*^*; Dlg3-Venus* IE HC showing Fltp, Dlg3-Venus, and Phalloidin co-localization (**E** and **E′**). The actin network, the CP, and the SC are marked by Phalloidin (Phall), Fltp protein by Fltp116-1 (Fltp), the kinocilium by acetylated-Tubulin (aT), the BB by pericentrin (Peric), the apical cell membrane by ZO-1, core PCP proteins by Vangl1 and Dvl2, and Dlg3-Venus fusion protein by GFP. Scale bars; 2 µm (**A**--**E′**), 3 µm (**F**--**H**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.014](10.7554/eLife.03842.014)

We tested this idea by analyzing Dlg3 and BB localization in Fltp mutants. When compared to WT ([Figure 8A--Dʹ,J](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}), the lateral crescent of Dlg3 in Fltp mutants is disturbed and BBs are not correctly positioned in the middle of the apical Dlg3 crescent ([Figure 8E--Hʹ,J](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}), implicating that Fltp binds to Dlg3 to position BBs, kinocilia, and stereocilia bundles. If Dlg3 and Fltp cooperate to position BBs, one would predict that these proteins physically interact. Dlg3 contains a central SH3 domain which could bind to the SH3 binding or PRR domain of Fltp. We tested this by co-immunoprecipitation experiments of Streptavidin-Flag (SF)-tagged Dlg3 variants and Fltp-myc variants from serum starved and ciliated HEK293T cells ([Figure 9A,B](#fig9){ref-type="fig"}). These experiments suggest a physical interaction of Fltp with Dlg3, which requires the highly conserved N-terminal SH3 binding domain of Fltp, but not the SH3 domain of Dlg3 ([Figure 9B](#fig9){ref-type="fig"}). As Dvl2 localizes directly adjacent to Dlg3 and Fltp in the inner ear, we next examined the association of endogenous Dvl2 and γ-Tubulin with overexpressed SF full-length Fltp and SF-Dlg3 ([Figure 9C](#fig9){ref-type="fig"}). The interaction of Dvl2 with Dlg3 and Fltp and γ-Tubulin with Dvl2 and Dlg3 suggests that these proteins form a complex during BB transport and positioning. Finally, we tested the predicted requirement of Dlg3 for BB positioning by knock-out analysis ([Figure 8K,L](#fig8){ref-type="fig"}, [Figure 8---figure supplement 1B,C](#fig8s1){ref-type="fig"}). Taken together, these results suggest that Dlg3 is a BB positioning protein that is anchored at apical TJs ([@bib41]) and cooperates with Fltp to position BB at the apical cortex of HCs in the cochlea at E18.5.10.7554/eLife.03842.015Figure 8.Loss of *Fltp* or *Dlg3* leads to BB mispositioning in IE hair cells.(**A**--**D**) LSM of *Fltp*^*+/+*^*; Dlg3-Venus* (*WT*) IE HCs at E18.5 reveals BBs in the middle of the lateral Dlg3-Venus crescent. (**B′**--**D′**) IMARIS surface rendering pictures of *WT* HCs. (**E**--**H**) LSM of *Fltp*^*ZV/ZV*^*; Dlg3-Venus* (*HOM*) IE HCs at E18.5. BBs are located at the edge of the lateral Dlg3-Venus crescent. The crescent itself often shows defective localization. The red asterisk marks some affected cells. (**F′**--**H′**) IMARIS surface rendering pictures of *HOM* HCs. For quantification see [Figure 8---figure supplement 1A](#fig8s1){ref-type="fig"}. (**I**) For BB mispositioning analyses the angle between the middle of the Dlg3-Venus crescent and the BB location was measured. (**J**) BB position in affected HCs of *HOM* animals significantly differs from the position in the *WT*. In total we analyzed n = 2 (73 cells) for *WT* and n = 2 (119) for *HOM*. (**K**) LSM of *Dlg3*^*−/−*^ (Dlg3^tm1Grnt^) IE HCs reveals mislocalized BBs and rotated hair cells. For quantification [Figure 8---figure supplement 1B,C](#fig8s1){ref-type="fig"}. (**L**) Analysis of BB mispositioning was performed as described in (**I**). BB position in affected HCs of *Dlg3*^*−/−*^ (*HOM*) animals significantly differs from the *Dlg3*^*+/+*^ (*WT*) position. In total we analyzed n = 7 (470 cells) for *WT* and n = 13 (804) for *HOM*. Statistical analysis uses an one-way ANOVA (**J**) or a Kruskal--Wallis test (**L**) (\*\*\*\*p \< 0.0001). Error bars show the 95% confidence interval of the mean. The actin network and stereocilia are marked by Phalloidin (Phall), BBs by pericentrin (Peric), cilia by acetylated-Tubulin (aT), and Dlg3-Venus fusion protein by GFP. Abbreviation: inner hair cell (IHC), outer hair cell (OHC 1-3). Scale bars; 10 µm (**A** and **E**), 1 µm (**B**--**D′**, **F**--**H′**, **K**).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.015](10.7554/eLife.03842.015)10.7554/eLife.03842.016Figure 8---figure supplement 1.BB mispositioning in *Fltp*^*ZV*^; *Dlg3-Venus* and *Dlg3* animals.(**A**) In *Fltp*^*ZV/ZV*^*; Dlg3-Venus* (*HOM*) IE significantly more hair cells across all rows show BB mispositioning over 8° (red) compared to controls *Fltp*^*+/+*^*; Dlg3-Venus* (*WT*). (**B**) The same analysis as in (**A**) only for *Dlg3*^*−/−*^ (*HOM*). *HOM* animals show higher number of cells with mispositioned BBs compared to *Dlg3*^*+/+*^ (*WT*) animals. (**C**) The deviation of hair cells from the polarity axis shows a clear PCP defect in *Dlg3*^*−/−*^ (*HOM*) animals (*WT* = blue, *HOM* = red). In total we analyzed n = 4 (1769 cells) for *WT* and n = 8 (583) for *HOM*. Statistical analysis uses a Kruskal--Wallis test (\*\*\*\*p \< 0.0001). Abbreviation: inner hair cell (IHC), outer hair cell (OHC 1-3).**DOI:** [http://dx.doi.org/10.7554/eLife.03842.016](10.7554/eLife.03842.016)10.7554/eLife.03842.017Figure 9.Fltp interacts with proteins associated with the TJ complex (Dlg3), the BB (γ-Tubulin) and with the core PCP protein Dvl2.(**A**) Dlg3 and Fltp constructs used for interaction domain mapping. (**B**) N-terminus of Fltp is essential for interaction with Dlg3. HEK293T cells were transfected with SF Dlg3 variants and with Fltp-myc variants. SF-tagged Dlg3 was immunoprecipitated using Streptavidin beads (Strep-IP). Full-length Fltp-myc was detected in the Strep-IP in the presence of full-length SF-Dlg3, SF-Dlg3ΔSH3, and SF-Dlg3ΔPDZ. FΔNT cannot be co-immunoprecipitated with SF-Dlg3. (**C**) Fltp and Dlg3 are found in a complex together with Dvl2 and γ-Tubulin. HEK293T cells were transfected with SF Dlg3 and SF Fltp. In a Strep-IP for Fltp and Dlg3, endogenous Dvl2 and γ-Tubulin were co-immunoprecipitated. Abbreviations: D: Dlg3; F: Fltp; SBD: SH3 binding domain; PRR: proline rich repeat.**DOI:** [http://dx.doi.org/10.7554/eLife.03842.017](10.7554/eLife.03842.017)

Discussion {#s3}
==========

Activation of the PCP pathway results in rearrangement of the actin and MT cytoskeleton via tissue specific effector molecules. Although actin and MT interactions need to be thoroughly controlled in virtually all cell types in different cell cycle phases across species from yeast to humans, it is surprising that not many adaptor proteins that mediate such interactions are identified ([@bib33]). These global cytoskeletal rearrangements underlie many fundamental morphogenetic processes in which cellular asymmetries need to be established and maintained, such as tissue morphogenesis, cell migration, or BB and spindle positioning in post-mitotic and mitotic cells, respectively ([@bib45]). We describe the identification and functional analysis of Fltp, a protein that orchestrates cytoskeletal rearrangements in cells that acquire PCP. Our data suggest, that Fltp is important for BB docking and positioning in mammals through regulating actin and MT interactions.

*Fltp* is a potential PCP effector gene that regulates MT--actin interactions in mammals {#s3-1}
----------------------------------------------------------------------------------------

Several lines of evidence suggest that Fltp is a potential PCP effector regulating the cytoskeleton. First, the *Fltp* gene and reporter are expressed in several tissues known to depend on active PCP signalling, such as the node, ependymal cells, floor plate, lung, eye, and IE. Second, *Fltp* expression kinetic correlates with dynamic PCP acquisition, terminal differentiation, and cellular morphogenesis in the lung and the IE. Third, the double knock-out of *Fltp* and the core PCP gene *Celsr1* show a more severe PCP phenotype than both single mutants, raising the possibility that both genes act in the same pathway, which needs further confirmation. If this is the case, then Fltp seems to be a downstream effector molecule in the PCP pathway, as it is not required for PCP establishment, but rather for cell intrinsic PCP transduction leading to cytoskeletal rearrangements. This is supported by the fact that phenotypes observed for the PCP effectors Intu and Fuz in the mucociliary epithelium of the frog and Fltp in the murine lung are strikingly similar ([@bib30], [@bib31]). Additionally, spindle positioning rather than core PCP mutant phenotypes mirrors the Fltp mutant phenotype in the IE ([@bib8]; [@bib40]). Finally, Fltp is localized at the interface of spindle positioning complexes that capture MT plus ends and connect to the PM and the apical actin cytoskeleton. Loss of Fltp leads to failure in BB docking and positioning most probably through disconnection of the BB, MT, and actin cytoskeleton in the mammalian lung and IE. Although the mechanisms of Fltp action in these two tissues might differ, a common theme seems that Fltp acts at the interface of the MT and actin cytoskeleton for BB docking and positioning, which we discuss in the following sections.

Fltp regulates BB docking and cilia formation in the lung {#s3-2}
---------------------------------------------------------

PCP is best studied in the mammalian IE, but is also apparent in MCCs of the lung and mucociliary epithelium of the frog skin ([@bib45]). In both terminally differentiated cell types, core PCP molecules are asymmetrically localized at the apical PM and translate long-range PCP signals into cell intrinsic cytoskeletal changes that coordinate BB docking and positioning as well as cilia formation in mono- and multiciliated cells. In MCCs of the frog skin the PCP effector proteins Intu and Fuz have been shown to control ciliogenesis and together with Dvl control apical docking and planar polarization of BBs by coordinating apical actin assembly ([@bib30], [@bib31]). It was further suggested that the PCP effector Fuz and Dvl2 control membrane trafficking and vesicle fusion at the BB essential for ciliogenesis ([@bib31]; [@bib11]). Studying Fltp function in the ALI primary cell culture system allowed us to link the onset of *Fltp* expression to the time of BB amplification, docking, and cilia formation. In MCCs, we have shown a close association of Fltp with the apical actin--MT cytoskeleton and BBs. Fltp localization at the apical surface is reminiscent of Dvl, Sec8, and Intu localization in frog multiciliated mucociliary epithelium ([@bib30]). Lack of Fltp function leads to BB docking defects and reduced number of cilia formed at the apical PM in ALI cultures and in vivo. Fltp physically interacts with Dlg3 and the core PCP molecule Dvl2, which regulates BB transport together with proteins of the secretory pathway ([@bib31]). We have previously shown that Dlg3 is the only Dlg family member that is monoubiquitinated by Nedd4 and Nedd4-like E3 ligases. This is required for apical PM transport mediated by the motor protein Dynein IC and Sec8, a component of the exocyst complex ([@bib41]). Thus, taken together, these findings suggest that Fltp cooperates with Dlg and Dvl family members to regulate apical BB transport and docking of BBs in multiciliated tissues. However, there is likely not a strong parallel between BB docking in MCCs and BB positioning in the IE, a topic which needs to be addressed in the future.

Fltp and the spindle positioning protein Dlg3 act in concert to position BBs in the IE {#s3-3}
--------------------------------------------------------------------------------------

To better understand the function of Fltp, we further focused our analysis on the IE as a well-described model for PCP. It was previously shown that core PCP molecules localize to distinct apical membrane compartments, but differential localization seems not sufficient to instruct morphogenesis of actin-rich hair bundles ([@bib15]). Instead, BB as well as kinocilium formation and positioning is essential for hair bundle morphogenesis, which is regulated by opposing localization of spindle positioning proteins and apical polarity proteins ([@bib8]; [@bib40]). mInsc, mPins/LGN, and Gα~i~ localize in a microvilli-free zone (bare zone) at the lateral side, whereas the apical polarity complex consisting of Partitioning defective 3 and 6 (Par3, 6) as well as atypical protein kinase C (aPKC) localize at the medial side. Surprisingly, localization of spindle proteins was not affected in the classical PCP mutants ([@bib8]), which either suggests redundancy in the PCP pathway or alternative mechanisms that position spindle proteins and BBs in the IE. We provide evidence that Fltp and Dlg3 position BBs and stereocilia bundles in the IE in addition to Gα~i~, mPins/LGN, and mInsc, suggesting that we have identified important new molecules for BB/spindle positioning in mammals. Dlg3 and Fltp together surround the BB and anchor this organelle asymmetrically to the apical cortex likely via Dvl2 and TJ-associated proteins on the one side and attachment to the apical actin cytoskeleton on the other side. We have recently shown that the scaffold protein Dlg3 is important for apical polarity and TJ formation by interaction with a number of TJ-associated proteins ([@bib41]). In the fruit fly, Dlg, Mushroom body defective (Mud), and Pins are absolutely necessary for spindle positioning in various cell types in vitro and in vivo ([@bib1]; [@bib14]; [@bib2]). The co-localization of Gα~i~, mPins/LGN and mInsc, and Dlg3-Venus in the bare zone further suggests that also in mammals these proteins act in concert to position BBs and spindles. Furthermore, the basolateral polarity complex consisting of Dlg, Lgl, and Scrib is known to establish membrane domains by reciprocal inhibitory interactions with the apical aPKC-Par3/6 polarity complex and to regulate A--B spindle positioning ([@bib17]; [@bib36]). These reciprocal inhibitory interactions of the apical and basolateral polarity complex at the apical surface further stabilized the positioning of BBs at the apical PM. But how spindle positioning complexes are linked to the actin cytoskeleton is still a mystery in mammals. In yeast, MT plus ends are captured by Kar9a, which binds directly to a type V myosin motor bound to actin filaments ([@bib18]; [@bib21]). As described above, Fltp functions very likely as a molecular adaptor protein localized between the interface of spindle positioning complexes and the apical actin cytoskeleton. Loss of Fltp function leads to disconnection of MT-based kinocilium and actin-based stereocilia bundles. Together, this suggests that Fltp couples BB/spindle positioning proteins to core PCP molecules and to the actin cytoskeleton in the IE. Further studies have to be conducted to precisely clarify how this complex is anchored to the cytoskeleton and core PCP components.

*Fltp* function in development and disease {#s3-4}
------------------------------------------

Knock-out analysis of *Fltp* revealed an important function in the terminal differentiation of multiciliated lung cells and the morphogenesis of stereocilia bundles on IE HCs. This emphasizes that PCP acquisition and remodeling of the actin- and MT-based cytoskeleton is crucially important for the maturation and function of terminally differentiated cell-types in tissues and organs. Consequently, mutations of both core PCP and effector molecules lead to a wide spectrum of ciliary dysfunction syndromes ([@bib10]; [@bib45]). For instance, in primary cilia dyskinesia, lack of directed mucociliary clearance and recurrent respiratory tract infections can eventually progress to permanent lung damage ([@bib38]). The *Fltp* knock-out mouse shows BB docking and cilia formation defects in MCCs of the lung as well as terminal airway constrictions. This suggests that human *FLTP* might be mutated in lung disease, a hypothesis that we are currently testing with our clinical partners. Moreover, mutation of Fltp leads to a stereocilia morphogenesis defect in the cochlea of the IE, which suggests that mutation of *FLTP* can cause hearing loss in human. Mutations in human *DLG3* are associated with X-linked mental retardation ([@bib23]) and we have previously identified that the scaffolding protein Dlg3 regulates apical polarity and TJ formation as well as PCP in the IE ([@bib41]). In this study, we have shown that Fltp and Dlg3 cooperate in BB positioning in the IE. As *Drosophila* Dlg acts as a tumor suppressor regulating proliferation and asymmetric cell division ([@bib14]), it is well possible that the Fltp--Dlg3 complex is involved in similar cellular processes in mammals. Indeed, we have evidence that Fltp regulates cell division of intestinal stem cells (Böttcher and Lickert, in preparation), suggesting that we identified a novel molecule with brought implication for ciliary disease and stem cell-mediated tissue homeostasis.

Materials and methods {#s4}
=====================

Animal data {#s4-1}
-----------

Mouse keeping was done at the central facilities at HMGU in accordance with the German animal welfare legislation and acknowledged guidelines of the Society of Laboratory Animals (GV-SOLAS) and of the Federation of Laboratory Animal Science Associations (FELASA). Post-mortem examination of organs was not subject to regulatory authorization.

Generation of Fltp antibodies {#s4-2}
-----------------------------

Fltp antibodies were generated as described previously ([@bib20]). Two affinity purified polyclonal antibodies (Fltp1, Fltp116-1) against mouse Fltp using the peptide sequence: DNPDEPQSSHPSAGHT for Fltp1 and KPFDPDSQTKQKKSVTKTVQ for Fltp116-1 were raised in rabbit (Pineda, Berlin, Germany). The Fltp1 epitope locates to the less well conserved C-terminal PRR ([Figure 1C](#fig1){ref-type="fig"}, red empty box). The Fltp116-1 epitope ([Figure 1C](#fig1){ref-type="fig"}, red filled box) resides N-terminal to the Fltp1 epitope and is less conserved in human.

Antibodies {#s4-3}
----------

Primary antibodies used were rabbit anti-Fltp1 (Pineda, Berlin), rabbit anti-Fltp116-1 (Pineda, Berlin), mouse anti-ZO-1 (33--9100: Invitrogen, Carlsbad, CA), mouse anti-α-Tubulin (T6199; Sigma), mouse anti-acetylated Tubulin (T7451; Sigma), mouse anti-γ-Tubulin (ab11316; Abcam), rabbit anti-β-Catenin (C2206; Sigma), chicken anti-GFP (GFP-1020; Aves Labs), rat anti-tyrosinated Tubulin (MAB1864; Millipore), rabbit anti-pericentrin (PRB-432C; Covance), rabbit anti-Vangl1 (HPA025235; Sigma), rabbit anti-Dvl2 (3216; Cell Signaling), and Alexa Fluor 546 Phalloidin (A22283; Invitrogen). Immunostainings were performed as described in the Supplemental 'Materials and methods'.

Western blot {#s4-4}
------------

Western blot analysis was performed by standard procedures. Following antibodies were used; mouse anti-Flag (A8592; Sigma), rabbit anti-Fltp1 (Pineda, Berlin), rabbit anti-Fltp116-1 (Pineda, Berlin), rabbit anti-Dvl2 (3216; Cell Signaling), mouse anti-γ-Tubulin (ab11316; Abcam), mouse anti-GAPDH (CB1001; Merck Bioscience).

X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) staining {#s4-5}
-----------------------------------------------------------

β-gal staining of whole-mount embryos and organs were performed as previously described ([@bib22]). Some tissues were further processed. Not BABB treated whole-mount embryos/organs were fixed, washed in PBS, and photographed. BABB treated embryos/organs were left in BABB for photographing.

SEM analysis {#s4-6}
------------

For SEM, inner ears were fixed in 2.5% glutaraldehyde in cacodylate buffer and then treated using standard procedures.

Generation of the Fltp^ZV^ targeting vector {#s4-7}
-------------------------------------------

The knock-in/knock-out construct was designed as shown in [Figure 3A](#fig3){ref-type="fig"}. 5ʹ and 3ʹ HR for the *Fltp* gene were amplified by PCR (449, 450, 451, 452) using a C57BL/6J BAC clone (RP23-333P11) as template. These two PCR products were subcloned into the pL254 vector ([@bib22])*.* The resulting vector was digested with *HindIII*, *SpeI* and electroporated into electrocompetent EL350 bacteria containing the *Fltp* BAC clone to retrieve the *WT* sequence between PCR homology arms resulting in the *Fltp* retrieval vector. For cloning of the knock-in/knock-out cassette in pBKS^−^ 5ʹ and 3ʹ HR for the knock-in into the ATG of exon, two of *Fltp* were generated by PCR (453, 454, 455, 456) using the previously mentioned BAC as a template and subcloned into pBKS^−^ using the introduced restriction sites, resulting in pBKS^−^-Fltp-HomArms. The targeting vector was generated by ligating the *loxP* flanked *neomycin* (*neo*) resistance cassette (PL-452) ([@bib24]) into the pBKS^−^-H2B-Venus-intron-SV40pA plasmid resulting in pBKS^−^-H2B-Venus-intron-SV40pA-loxP-bGHpA-neo-EM7-PGK-loxP (pBKS^−^-H2B-Venus-neo). The T2A sequence from *Thosea asigna* virus was introduced into the *NotI* site of pBKS^−^-H2B-Venus-neo by annealing the following oligos 2A_fwd; 2A_rev, which created a *NotI* compatible overhang resulting in pBKS^−^-2A-H2B-Venus-neo. NLS-lacZ (nuclear localization signal-β-galactosidase fusion protein) was ligated into the pBKS^−^-2A-H2B-Venus-neo vector resulting in pBKS^−^-NLS-lacZ-2A-H2B-Venus-neo. To finish the minitargeting construct, we cloned pBKS^−^-NLS-lacZ-2A-H2B-Venus-neo into pBKS^−^-Fltp-HomArms (both cut with *NotI* and *SalI*). The minitargeting construct was cut out by *SacII* and *KpnI*, electroporated in EL350 bacteria, and introduced into PL254 via bacterial homologes recombination resulting in the final targeting construct (PL254-Fltp-NLS-lacZ-2A-H2B-Venus-intron-SV40pA-loxP-bGHpA-neo-EM7-PGK-loxP) which was confirmed by sequencing and is ready for electroporating into embryonic stem (ES) cells (after linearization by *AscI*).

Generation of the Fltp knock-out mouse line and Southern blot {#s4-8}
-------------------------------------------------------------

To generate targeted ES cells, we electroporated IDG3.2-F1 ES cells (C57BL/6J x 129S6/SvEvTac) ([@bib12]) with the *AscI*-linearized FltpZV targeting vector and neomycin resistant clones were selected using 300 µg/ml G418 (Invitrogen). Homologous recombination at the *Fltp* locus was confirmed by Southern blot analysis of *DraIII*-digested genomic DNA using the Fltp 5ʹ-probe (620 bp) (5ʹ S Fltp FWD *XhoI*; 5ʹ S Fltp REV *XbaI*). 8 out of 100 clones (in total: 22 positive clones out of 289) showed homologous recombination. Due to restriction fragment length polymorphisms (RFLP) of the Bl/6J and 129S6 alleles and an isogenic Bl6 targeting vector, homologous recombination occurred preferentially on the Bl/6J allele and reduced the size of the restriction fragment from 16.443 bp to 11.469 bp. The 129S6 WT band is smaller in size than the Bl/6J WT band and is not targeted. Both ES cell clones gave birth to Δneo animals, but for the analysis we concentrated on one clone and founded the animal colony on this. After deletion of the neo cassette mice were backcrossed to C57Bl/6J to eliminate the *Cre* allele. Only those mice negative for the *Cre* allele were used for backcrossings to C57BL/6NCrl, 129S6/SvEvTac, or CD1 and further analyses were carried out with *Fltp*^*ZVΔneo/+*^ mice backcrossed several generations in C57BL/6NCrl, 129S6/SvEvTac, or CD1.

Generation of the Dlg3:Venus mouse line {#s4-9}
---------------------------------------

The Dlg3-Venus mouse line was generated by electroporating a pCAG-Venus-Dlg3 construct into IDG3.2-F1 ES cells (C57BL/6J x 129S6/SvEvTac). Positive ES cells were aggregated with CD1 morulae and the resulting chimeras gave germ-line transmission of the Dlg3-Venus allele.

Isolation of mouse tracheal epithelial lung cells and ALI culture {#s4-10}
-----------------------------------------------------------------

Isolation of mouse tracheal epithelial cells (mTECs) and air liquid interface (ALI) culture was performed as described in Vladar and Brody ([@bib43]).

Mice were sacrificed and the trachea dissected out. The trachea was put into ice cold HamF12 medium supplemented with penicillin/streptomycin (P/S). Tissue surrounding the trachea was removed under the dissecting microscope in HamF12 medium. The trachea was digested in HamF12 medium supplemented with 1.5 mg/ml pronase (protease 14) at 4°C ON. On the next day the tube was put on ice, FBS (fetal bovine serum) was added to a concentration of 10% and the tube was inverted at least 12×. The tracheas were transferred into a new tube with HamF12 P/S 10% FBS medium and again inverted 12×. Tracheas of the same genotype can be pooled and centrifuged for 10 min at 4°C at 400×*g*. 200 µl HamF12 P/S per trachea were supplemented with 0.5 mg/ml DNaseI and 10 mg/ml BSA (bovine serum albumin), the trachea were resuspended and incubated for 5 min on ice. Subsequently, the tubes were centrifuged for 5 min at 4°C at 400×*g*. The cells were resuspended in MTEC basic medium (DMEM F12 \[\#21331-020; Invitro\], 15 mM HEPES \[1M stock\], 3.6 mM sodium bicarbonate, 4 mM L-Glut \[200 mM stock\], P/S \[100Glu× stock\], Fungizone \[500× stock\]) with 10% FBS and incubated for 3--4 hr at 37°C. The supernatant was collected, centrifuged for 5 min at 400×*g*, and resuspended in 100--200 µl MTEC plus medium (MTEC basic, 10 μg/ml insulin (5 mg/ml stock), 5 μg/ml transferrin (5 mg/ml stock), 0.1 μg/ml cholera toxin (100 μg/ml stock), 25 ng/ml EGF (25 μg/ml stock), 30 μg/ml BPE, 5% FBS, 0.01 μM RA) for counting. 75.000 cells per cm^2^ were seeded on a transwell filter in MTEC plus medium. The medium was changed every 2 days. When the cells were confluent the MTEC culture was changed to an ALI culture by removing the medium on top of the filter and providing only medium supply from the bottom.

Immunoprecipitation {#s4-11}
-------------------

For the interaction analysis, we used HEK293T cells transfected with Fltp-TAP-TAG and as a control HEK293T cells only transfected with TAP-TAG.

The cells were rinsed with warm PBS and lysed with 1 ml ice cold lysis buffer (50 mM Tris/HCl, pH 7.4, 150 mM sodium chloride, 2 mM EDTA, pH 8, 1% Nonidet P-40, filtrate sterile) per 10 cm dish on ice. Cells were spinned down for 10 min at 10000×*g* at 4°C. Lysates were cleaned by filtration through syringe filters (MILLEX GP, 0.22 µm, Millipore). 1 mg of the filtered lysate was incubated with 50 µl Strep-Tactin superflow resin (IBA) in 1 ml of lysis buffer for 1 hr at 4°C in an overhead tumbler. The protein--Strep-Tactin solution was spinned down for 30 s at 7000×*g* and transferred to microspin columns (GE-Healthcare). The supernatant was spinned down for 5 s at 100×*g*, washed three times with 500 µl TBST (100 mM Tris/HCl, pH 7.4, 1.5 M sodium chloride, 1.0% Tween20), and centrifuged for 5 s, 100×*g*. The protein was eluted by 500 µl desthiobiotin elution buffer (IBA) and incubated for 10 min while mixing the resin for several times. The elute can now be used for western blot analysis.

Immunohistochemistry on cryosections and whole-mount immunohistochemistry {#s4-12}
-------------------------------------------------------------------------

Dissected tissues were fixed in 4% paraformaldehyde (PFA) and cryoprotected by incubation in a sucrose gradient for at least 1 hr each (5%, 15%, 30%). Tissues were frozen in OCT (optimal cutting temperature) after which immunohistochemical staining was carried out on 8- to 12-µmthick sections, mounted on glass slides. Briefly, sections were rehydrated in PBS, permeabilised for 10 min in 0.1 M glycine/0.1% Triton X-100 in PBS, and blocked for 1 hr in 5% donkey serum/PBS-Tween 0.1% (PBS-T). Finally, the sections were incubated with the primary antibody in blocking solution ON at 4°C. The slides were washed with PBS-T, incubated with the secondary antibody in PBS for 2 hr at RT, washed with PBS, incubated with DAPI, and finally mounted with ProLong Gold antifade reagent (P36930; Invitrogen). Whole-mount immunohistochemistry was performed as previously described ([@bib29]). Briefly, embryos were isolated, fixed for 20 min in 2% PFA in PBS, and then permeabilized in 0.1% Triton X-100 in 0.1 M glycine pH 8.0. After blocking in 10% FCS, 3% goat serum, 0.1% BSA, 0.1% Tween 20 for 2 hr, embryos were incubated with the primary antibody ON at 4°C in blocking solution. After several washes in PBS-T, embryos were incubated with secondary antibodies in blocking solution for 3 hr. During the final washes with PBS-T, embryos were stained with DAPI, transferred into 40% glycerol, and embedded between two coverslips using 120 µm Secure-Seal spacers (S24737; Invitrogen) and ProLong Gold antifade reagent.

Immunohistochemistry on inner ears {#s4-13}
----------------------------------

Whole-mount inner ears were isolated, fixed for 20 min in 4% PFA in PBS, then the cochlea was dissected out, permeabilized in 0.1% Triton X-100 in 0.1 M glycine pH 8.0. After blocking in 10% FCS, 3% goat serum, 0.1% BSA, 0.1% Tween 20 for 25 min, ears were incubated with the primary antibody ON at 4°C in blocking solution. After several washes in PBS-T, embryos were incubated with secondary antibodies in blocking solution for at least 3 hr. During the final washes with PBS-T, embryos were stained with DAPI. Alternatively ears were fixed/permeabilized for 10 min in 0.25% glutaraldehyde, 3.7% PFA, 3.7% sucrose, and 0.1% Triton X-100 in PHEM buffer (60 mM Pipes, 25 mM Hepes, 5 mM EGTA, 1 mM MgCl), the cochlea was dissected out and again fixed/permeabilized for 10 min in the same solution as above. After PBS washes blocking as described above was carried out. Finally, ears were embedded in a spacer between two cover slips.

Immunohistochemistry on ALI cultures {#s4-14}
------------------------------------

Antibody staining of ALI cultures was performed by cutting out, washing (PBS), and fixing (ice cold MeOH, 4% PFA, or fixed/permeabilised in 0.25% glutaraldehyde, 3.7% PFA, 3.7% sucrose, and 0.1% Triton X-100 in PHEM buffer depending on the primary antibody used) the Transwell membrane. Subsequently, membranes were treated as described above. Finally, membranes were embedded in a spacer between two cover slips.

Genotyping of mouse lines {#s4-15}
-------------------------

Genotyping of the Fltp^ZV^ mouse line (after Cre-mediated excision of the neomycin selection cassette) was performed using the forward primer 566 and 418 as well as the reverse primer 565. With an annealing temperature of 57°C and 35 cycles, this PCR amplified a WT product of 317 bp and a targeted of 387 bp.

For genotyping of the Dlg3:Venus mouse line, the forward primer 180 and the reverse primer 181 were used. A PCR performed with an annealing of 60°C and 32 cycles amplifies a product of 312 bp.

Genotyping of Dlg3 mouse line was performed using the forward primer 534 and the reverse primer 535 as well as the reverse primer 536. Amplification of 33 cycles with an annealing of 58°C yielded a WT product of 535 bp and a 215 bp product for the targeted allele. The gene trap clone P038A02 (R1 on a pure 129Sv6 genetic background) was obtained from the German Gene Trap Consortium. Dlg3tm1Grnt/Y male and Dlg3tm1Grnt/+ female mice on a C57Bl/6 background were genotyped as previously described ([@bib6]).

For genotyping of the Fltp^ZV^; Celsr1^Crsh^ mouse line, we first performed a PCR with the forward primer 779 and the reverse primer 780 resulting in a 321 bp band. Next, we purified the PCR product via the PCR purification kit and sequenced the product in both directions. The adenine of the WT sequence was replaced by a guanine in the mutated sequence. For the Fltp^ZV^ genotyping, we used the protocol described above.

Isolation of embryos and organs {#s4-16}
-------------------------------

Dissections of embryos and organs were carried out according to Nagy and Behringer ('*Manipulating the mouse embryo: a laboratory manual*'). Embryos were staged according to Downs and Davies ([@bib7]).

Tissue clearing with BABB {#s4-17}
-------------------------

Tissues were dehydrated through a methanol/H~2~O series: 2 hr in 25% methanol/H~2~O, 2 hr in 50% methanol/H~2~O, 2 hr in 75% methanol/H~2~O, and ON in 100% methanol. Finally the tissue was transferred to BABB for clearing.

Whole-mount in situ hybridization {#s4-18}
---------------------------------

Whole-mount in situ hybridization was performed as previously described and Fltp mRNA was transcribed from a sequence-verified cDNA clone ([@bib39]).

Paraffin sections {#s4-19}
-----------------

After in situ hybridization or lacZ staining, the embryos were dehydrated via a methanol series (25%, 50%, 75%, 2 × 100%) for 10 min per step. To clear the embryos, we incubated 2× in xylol for 5--10 min (depending on the thickness of the specimen). For tissue penetration of the paraffin, the specimen was left in paraffin at 65°C ON. On the next day, they were transferred into fresh paraffin and incubated at 65°C ON. The embryos were orientated and embedded into a mold. The cooled down paraffin blocks were mounted onto a grid and sectioned on a microtome. The sections were mounted on glass slides, dried ON at 37°C, dewaxed in xylol (2 × 15 min), fixed with mounting medium, and covered with a cover slip. After one night at 4°C, the sections were ready for microscopical analyses.

Histological staining of paraffin sections using Nuclear Fast Red (NFR) {#s4-20}
-----------------------------------------------------------------------

First, paraffin sections on glass slides were dewaxed twice for 15 min in xylene. An alcohol row (100%, 90%, 80%, 70%, 1 min each) for rehydration followed and ended in H~2~O. Afterward, the slides were dipped into NFR for 1 min and thoroughly washed with dist. H~2~O. Then, a dehydration step followed within an afferent alcohol row (70--100%, see above). Finally, the slides were incubated twice in xylene for 15--30 min and once in Roti-Histol for 15--30 min. After incubation in Roti-Histol, slides were put on a paper towel, sprinkled with a few drops mounting medium, and covered with a cover slip.

Statistical analysis {#s4-21}
--------------------

Statistical significance was calculated using Prism (GraphPad Software). Circular statistics were done using MATLAB and R.

Image acquisition and analysis {#s4-22}
------------------------------

Image acquisition was performed on a Leica DMI 6000 confocal microscope or on a Zeiss Lumar.V12 Stereo using an AxioCam MRc5 camera. Image analysis was performed with Leica LAS AF software, AxioVision (Zeiss), and Imaris 7.6.4 (Bitplane, Zürich, Switzerland).

Oligonucleotides for cloning {#s4-23}
----------------------------

5ʹ S Fltp FWD: 5ʹ-NNNCTCGAGGAGCCCTTACGCACACTTAAG-3ʹ5ʹ S Fltp REV: 5ʹ-NNNTCTAGACGGGACATTAACTGCATCTTATCTGAGGTTG-3ʹ011: 5ʹ-NNNACTAGTAGGTAAGTGTACCCAATTCGCCCTATAG-3ʹ012: 5ʹ-NNNGGATCCACGCGTTAAGATACATTGATGAGTTTGGAC-3ʹ013: 5ʹ-NNNTCTAGAATGGTGAGCAAGGGCGAGGAGCTGTTC-3ʹ014: 5ʹ-NNNACTAGTTTACTTGTACAGCTCGTCCATGCCGAGAG-3ʹ025: 5ʹ-NNNGCGGCCGCGCCACCATGCCAGAGCCAGCG-3ʹ026: 5ʹ-NNNTCTAGACTTAGCGCTGGTGTACTTGGTGATGG-3ʹ340: 5ʹ-NNNGCGGCCGCGCCACCATGAACCTTGAAGCTCGAAAAACAAAG-3ʹ341: 5ʹ-NNNGGCGCGCCTTTTTGACACCAGACCAACTGGTAATGGTAGC-3ʹ449: 5ʹ-NNNGGCGCGCCAGTCAGGAAGTGGAAGAGAAGAACACAG-3ʹ450: 5ʹ-NNNAAGCTTACTAGTGTGGTGGAGTGCCTGTCTACATGTG-3ʹ451: 5ʹ-NNNAAGCTTCACGACAGTCAAAGCTGCAATAGAAC-3ʹ452: 5ʹ-NNNGGATCCGGTAATTTGGCAATTATAGAACTCAGGC-3ʹ453: 5ʹ-NNNCCGCGGAGCAGACTTAACTATGTTGGGGAAACAGC-3ʹ454: 5ʹ-NNNGTCGACGCGGCCGCTGTTTACACTTGTTGCCTGGCAACTG-3ʹ455: 5ʹ-NNNGTCGACGGTCCTAGTCTAGCTGAGGTCCAGATC-3ʹ456: 5ʹ-NNNGGTACCATGCTGTGGGAGTCACTGACATTCTTG-3ʹ

Oligonucleotides for genotyping {#s4-24}
-------------------------------

180: 5ʹ-GTGAACCGCATCGAGCTGAAGG-3ʹ181: 5ʹ-GAACTCCAGCAGGACCATGTG-3ʹ418: 5ʹ-AGCCATACCACATTTGTAGAGG-3ʹ534: 5ʹ-GGTCTCTGATGAAGCAGTGATTTTT-3ʹ535: 5ʹ-TGATGACCCATAGACAGTAGGATCA-3ʹ536: 5ʹ-CTAAAGCGCATGCTCCAGAC-3ʹ565: 5ʹ-CAGCATGGCATAGATCTGGAC-3ʹ566: 5ʹ-GAGGCTGACTGGGAACAATC-3ʹ779: 5ʹ-ACAACCTTTGGGCTCTCG-3ʹ780: 5ʹ-TATAGTCCCTCCGGACCTC-3ʹ
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Flattop and Dlg3 cooperatively translate planar cell polarity cues for basal body positioning" for consideration at *eLife*. Your article has been favorably evaluated by Fiona Watt (Senior editor), Jeremy Nathans (Reviewing editor), and 3 reviewers.

The manuscript has been reviewed by three expert reviewers, and their assessments together with my own, forms the basis of this letter. I am including the three reviews (lightly edited) at the end of this letter, as there are many specific and useful suggestions in them that will not be repeated in the summary here.

All of the reviewers were impressed with the importance and novelty of your work. Overall, the experiments appear to be carefully executed. However, all three reviewers believe that the data is over-interpreted in many places, and that this detracts from the manuscript. In particular, the evidence for a direct connection with PCP is circumstantial. There are also significant questions related to the data presented in [Figures 3 and 4](#fig3 fig4){ref-type="fig"}, and [Figure 4--figure supplement 1](#fig4s1){ref-type="fig"}.

We would like to encourage you to resubmit a revised manuscript that addresses the specific issues raised in the reviews below. With respect to the writing, I can appreciate that in the current publishing environment one feels compelled to impress editors and reviewers, which leads to an almost irresistible temptation to over-state one\'s own conclusions. *eLife* is trying to restore some balance to the world of scientific writing; we welcome self-critical comments and we believe that such comments actually enhance the reader\'s ability to judge the science fairly.

I will offer two examples of scientific writing that I think illustrates the preceding point. They are from two papers on ubiquitin that form the core of the discoveries for which the authors shared the Nobel Prize.

Proposed role of ATP in protein breakdown: conjugation of protein with multiple chains of the polypeptide of ATP-dependent proteolysis.

Hershko A, Ciechanover A, Heller H, Haas AL, Rose IA. Proc Natl Acad Sci U S A. 1980 Apr;77(4):1783-6.

In the second paragraph of the Discussion section, after summarizing the evidence that leads the authors to propose the conjugation of APF-1 (=ubiquitin) to proteins as a way of marking them for degradation, the authors write : "Evidence that APF-1-proteins are intermediates in the breakdown of denatured protein as proposed in [Fig. 6](#fig6){ref-type="fig"} is indirect and inconclusive at this time."

Activation of the heat-stable polypeptide of the ATP-dependent proteolytic system.

Ciechanover A, Heller H, Katz-Etzion R, Hershko A. Proc Natl Acad Sci U S A. 1981 Feb;78(2):761-5.

In the last paragraph of the Discussion section, after describing their discovery and characterization of ubiquitin ligase, the authors write "Evidence suggesting the role of the APF-1-activating enzyme in conjugation and in ATP-dependent protein breakdown is not conclusive at present."

Reviewer \#1:

In this work, Moritz Gegg et al. study Fltp mutant mice and present evidence that Fltp plays a role in cilia docking by interacting with Dlg3. Since the work is based on studies of mutant mice and cells, it is very strong and I like the study very much.

I regret that several results are a bit overstated and/or not fully supported by the morphological illustrations provided. The main point is to tone down some overstated claims at several places in the text. As it is written, the paper presents a fully demonstrated model that is supported by the data but not yet demonstrated beyond reasonable doubt. The last part of the Introduction is a good example of what I mean. The whole discussion is unfortunately hyperbolic along the same lines.

I understand that formal proof of the model cannot be provided using reagents available and therefore the authors should not be required to do additional experiments.

On the other hand, they should pay attention and significantly edit their text to make it less speculative and more factual. I also have some remarks about figures.

1\) Introduction:

In MGI, five Dlg genes are mentioned, each has been inactivated separately and Dlg1 is clearly the most critical, with neonatal lethality; intriguingly, Dlg3 knock-outs are reported to be viable and fertile.

2\) Results:

a\) Authors mention the presence of two P-rich domains in Fltp. P-rich regions are not detected using "conserved domain" (Entrez website), and the concentration of P in the boxed in [Figure 1](#fig1){ref-type="fig"} does not seem that high. What criteria are used to support the existence of those two domains?

b\) For antibody specificity ([Figure--1 figure supplement 1A](#fig1s1){ref-type="fig"}), is the alpha-tubulin a cross reaction? If yes, why are microtubules not seen in immunostained cells ([Figure 1--figure supplement 1E](#fig1s1){ref-type="fig"})? It should be explicitly mentioned that the Abs were validated by immunocytochemistry in transfected cells.

c\) [Figure 2--figure supplement 1 F-I](#fig2s1){ref-type="fig"}\' and associated text: I cannot see endogenous Fltp green localization in monocilia. Could the figures be improved?

d\) [Figure 4](#fig4){ref-type="fig"} and associated text: This requires better explanations and/or illustrations. The text and legend do not allow the reader to understand [Figure 4E](#fig4){ref-type="fig"}. Similarly, it is not very clear that Fltp localizes along the length of cilia (B,B\'). This being said, the defective docking of BB in culture is very convincing, more than what is described in vivo in [Figure 3](#fig3){ref-type="fig"}. How can this be explained?

e\) Inner ear, [Figure 5](#fig5){ref-type="fig"}. From 5C, I have the impression that PCP in IHC is even more disturbed than in OHC, and seems to be confirmed in the quantification N. However, Fltp is said to be expressed on in OHC. Does this mean that Fltp has some non-cell autonomous effects, or that low expression is present in IHC?

f\) For quantification, authors mention ANOVA; it is probably acceptable for relatively small angles, less than 40^o^ in this series of data. Still, authors should be aware that comparison of angles is usually done using circular statistics, because arithmetic mean of angles is not meaningful.

g\) The addition of phenotypes in Celsr1+Fltp mutants is interesting and worth showing. On the other hand, I do not think that this indicates that both proteins act in the same PCP pathway; they could just as well act in two parallel pathways. I think the text should be modified to take this into account. I also do not understand why authors looked at the localization of Vangl1 rather than Vangl2; which has a stronger action in PCP - for which good Abs are available commercially.

3\) Last part of Results and [Figure 7](#fig7){ref-type="fig"}.

The subtitle and the following text are too strong. The data shown in [Figure 7](#fig7){ref-type="fig"} are really informative, yet colocalisation does indicate but no prove interaction. The change in localization upon inactivation of Fltp, illustrated in [Figure 8](#fig8){ref-type="fig"}, provide a stronger argument for interaction than simple colocalisation, and the Co-IP in HEK cells is also a strong indication. As authors know and although their data are strong, interactions should be demonstrated using techniques such as IP in vivo, or FRET and others. I agree that this is undoable given the reagents available. However, given this intrinsic limitation, strong claims are not acceptable and should be significantly tuned down.

4\) As mentioned above, the Discussion, although scholarly and informative, is somewhat hyperbolic and should be more nuanced. I would also like to have the opinion of the authors on why the effect on cilia docking is present only in some cells, whereas Fltp seems to be a unique gene without paralog.

Reviewer \#2:

The authors present data showing that Fltp has a function in localizing basal bodies in multiciliated airway cells and in cochlear hair cells. Fltp is expressed in many ciliated cells where the PCP pathway functions. In fltp mutant MCCs, BBs fail to dock, and in mutant cochlea, BB/kinocilia are mispositioned and stereocilia bundles are misoriented and distorted. Fltp localizes apically in both cell types. The authors also describe, using a mutant, a function for Dlg3 in orienting BB/kinocilia. Finally, they show that transfected Fltp and Dlg3 co-IP, and that gamma tubulin and Dvl2 are also pulled down. These data could perhaps make a reasonable story that Fltp is involved in BB positioning in several cell types. However, the manuscript is written in such a way to substantially over-interpret their data, and a number of important holes in the data exist. As an appropriately described piece of work, it would be an editorial decision as to whether the results merit publication in this journal.

The overreaching interpretation of the results is evident with regard to several points. The authors devote considerable discussion to how Fltp participates in linking tubulin and actin in these processes, based only on the localization data and the phenotype, without any ultrastructure or biochemistry to support these conclusions. This discussion should all be deleted from the main text, and relegated to speculation in the Discussion.

A considerable omission is the failure to examine a potential role for Dlg3 in MCCs. Is there any MCC phenotype in the mutant? If not, how should one interpret the docking defect in comparison to the hair cell phenotype? This highlights the problem that there is not a strong parallel between BB docking in MCCs and BB positioning in hair cells.

A third substantial and related problem is that the model is very unclear. The cartoon suggests that Fltp localizes to stereocilia, but the binding data suggest it should be found with gamma tubulin at the BBs. Finally, the authors discuss function at the TJs. Since MCCs don\'t have the equivalent of stereocilia, where is the commonality? In these cells, Fltp is seen in the apical meshwork, but the resolution is too low to make specific conclusions about exactly where. We know too little to extract any inference about commonality of Fltp function from the two cell types.

There is one very troubling piece of data that must be explained, and unsatisfactory resolution will invalidate the MCC findings. The IMARIS resonstructions in [Figure 4](#fig4){ref-type="fig"} HI show mostly docked vs many undocked BBs, but it is normally easy to find cells in day 4 cultures with undocked BBs, as cells continue to differentiate for some time. Care must be taken that these are representative. Therefore the quantitative data are essential. The MTEC data from day2 and day4 shown in [Figure 4-figure supplement 1](#fig4s1){ref-type="fig"} are at best, extremely confusing, and at worst, suggest the possibility that the results should be discarded. First, it is unclear what the authors are measuring. The number of BBs? The number or percent of docked BBs? Number of cells with docked BBs? This must be made clear. Furthermore, in this highly reproducible system, at ALI+2 days, there are only very few cells with multiple cilia, yet the authors\' data seem to suggest that 80% of the cells are multiciliated (to completion??). In the best wildtype cultures, 80% of cells are never seen to become multiciliated. Furthermore, by day 4, the number has declined to 60%? Why? At this stage, the numbers should still be increasing. In light of this, how are we to interpret the mutant results? We need a description of what is being measured, as well as images to corroborate.

Another problem is with the "genetic interaction" between fltp and celsr1. Genetic interaction is typically shown between heterozygotes that have no phenotype on their own, or between one het with no phenotype and a homozygote with a weak phenotype. The authors make double homozygous mutants and show an enhanced phenotype. Yet each homozygote has a phenotype of its own, and therefore the result could simply be an additive phenotype. The result therefore DOES NOT show a genetic interaction and provides NO EVIDENCE that Fltp is in the PCP pathway. The result is equally consistent with distinct pathways converging on a shared output. Numerous other statements describing Fltp function in PCP signaling are also misleading. For example, describing Dvl2 function at BBs as a PCP function is not valid. Indeed, the MCC phenotype is not a PCP phenotype at all, and the hair cell phenotype impacts PCP, but is presumably quite downstream. Taken together, it is not reasonable to describe the results as being effectors of PCP. This is another big example of interpretation not correctly reflecting the findings.

Reviewer \#3:

This paper reports the discovery of a novel gene that acts as an essential downstream effector of PCP function in ciliated cells. Overall the paper is quite interesting and if correct would provide a good addition to the literature in this area, though there are several issue that must be resolved before publication can be considered. Moreover, many conclusions are overstated, and unnecessarily so, since the story is a good one even without the overreach.

The paper identified flattop in a screen for targets of foxa2, and this new gene is expressed in ciliated cells. Mutant mice display defects in the airway cilia as well as defects in kinocilium polarity in the cochlea, and these are traced to defects in basal body positioning. In the cochlea, fltp shows genetic interaction with the core PCP protein celsr1. The authors then show that the tight junction protein Dlg3 localizes to an interesting pattern in the cochlear hair cells and that fltp and dlg3 functionally and physically interact to control basal body position.

1\) Many references are made to "Detailed" subcellular co-localization studies. But these data are not at all clear in their current form. In particular the data in [Figure 3](#fig3){ref-type="fig"} are over-interpreted. It is stated that Fltp "specifically" colocalizes with newly synthesized MT plus-ends, but [Figure 3B](#fig3){ref-type="fig"} shows much green where there is no red and much of the converse as well.

2\) The claim is made in [Figure 3](#fig3){ref-type="fig"} that fltp is localized to the apical but not the sub-apical actin in multiciliated cells, yet [Figure 3A](#fig3){ref-type="fig"} shows only a single x/y image and [Figure 3c](#fig3){ref-type="fig"} shows Zo1, but not actin. How is this claim justifiable from these data?

3\) The authors need to comment on the possible role for fltp in basal body amplification. According to [Figure 5](#fig5){ref-type="fig"}, the most obvious phenotype in the mutants may not be BB docking, but the reduction in BB numbers. This issue is a big one because recent work on cyclin O from Kinter and Omran shows that BB docking and amplification may be linked.

10.7554/eLife.03842.019

Author response

Reviewer \#1:

1\) Introduction: *In MGI, five Dlg genes are mentioned, each has been inactivated separately and Dlg1 is clearly the most critical, with neonatal lethality; intriguingly, Dlg3 knock-outs are reported to be viable and fertile*.

The reviewer is right and we corrected this in the manuscript. However, Dlg3 KOs show low penetrance embryonic lethality which we have published recently (Van In mammals, four Dlgs et al., 2011; Dev Cell): "From E8.5 onward, Dlg3 mutants are statistically underrepresented, and mutants displayed incompletely penetrant defects in embryonic turning, failure of chorioallantoic fusion, posterior truncations (n = 16 out of 38), and lack of anterior neural induction (n = 6 out of 38; [Figures 1A and 1B](#fig1){ref-type="fig"}). Dlg3tm1Grnt null embryos also show occasionally an open brain phenotype (n = 8 out of 38; [Figure 1--figure supplement 1B and1C](#fig1s1){ref-type="fig"}). Taken together, both the Dlg3GtP038A02 and Dlg3tm1Grnt mutant alleles cause embryonic lethality with low penetrance."

Change:

"In mammals, four Dlgs have been identified and we have recently shown that their function has diverged during evolution ([@bib41])."

To:

"In mammals, five Dlgs have been identified and we have recently shown that their function has diverged during evolution ([@bib41])."

2\) Results:

*a) Authors mention the presence of two P-rich domains in Fltp. P-rich regions are not detected using "conserved domain" (Entrez website), and the concentration of P in the boxed in* [*Figure 1*](#fig1){ref-type="fig"} *does not seem that high. What criteria are used to support the existence of those two domains?*

For identification of the PRRs we used the protein domain prediction tools (MyHits, HYPERLINK "http://hits.isb‐sib.ch/cgi‐bin/motif_scan" \\o "http://hits.isb‐sib.ch/cgi‐bin/motif_scan"http://hits.isb‐sib.ch/cgi‐bin/motif_scan and Scansite, HYPERLINK "http://scansite.mit.edu" \\o "http://scansite.mit.edu/"<http://scansite.mit.edu>). The C-terminal PRR (138-184) was identified by MyHits.Author response image 1.

Unfortunately confusion occurred about the N-terminal PRR. The domain is now annotated as a SH3 binding domain identified by Scansite. However, PRRs are also known to be SH3 binding domains. We apologise for the mistake and we updated this in the manuscript and the figure (see below). We found Grb2 as an interaction partner in a Fltp interactome study indicating that this predicted Grb2 SH3 binding domain might be functional. Additionally, we showed that the N-terminal SH3 binding region of Fltp is important to bind Dlg3 (a SH3 domain containing protein, see [Figure 9](#fig9){ref-type="fig"}).Author response image 2.

Changes:

"An alignment of the proteins of different species reveals a high conservation during evolution as well as N- and C-terminal proline-rich repeats (PRR) ([Figure 1C](#fig1){ref-type="fig"})."

To:

"An alignment of the proteins of different species reveals a high conservation during evolution as well as a N-terminal SH3 binding domain and a C-terminal proline-rich repeat (PRR) ([Figure 1C](#fig1){ref-type="fig"})."

"The mouse and human proteins are highly homolog (clear green boxes: predicted proline rich repeats (PRRs); red filled box: peptide sequence of the Fltp116-1 epitope; red empty box: peptide sequence of the Fltp1 epitope; dark blue indicates conservation over 80%; lighter colors indicate less conservation)."

To:

"The mouse and human proteins are highly homolog (yellow box: SH3 binding domain; green box: predicted proline rich repeat (PRR); red filled box: peptide sequence of the Fltp116-1 epitope; red empty box: peptide sequence of the Fltp1 epitope; dark blue indicates conservation over 80%; lighter colors indicate less conservation)."

Abbreviations: D: Dlg3; F: Fltp

To:

Abbreviations: D: Dlg3; F: Fltp; SBD: SH3 binding domain; PRR:Proline rich repeat.

"The Fltp1 epitope lies in the PRR of the less well conserved C-terminal part of the Fltp protein ([Figure 1C](#fig1){ref-type="fig"}, empty box). The Fltp116-1 epitope ([Figure 1C](#fig1){ref-type="fig"}, filled box) resides N-terminal to the Fltp1 epitope and is less conserved in human."

To:

"The Fltp1 epitope locates to the less well conserved C-terminal PRR ([Figure 1C](#fig1){ref-type="fig"}, red empty box). The Fltp116-1 epitope ([Figure 1C](#fig1){ref-type="fig"}, red filled box) resides N-terminal to the Fltp1 epitope and is less conserved in human."

*b) For antibody specificity (*[*Figure--1 figure supplement 1A*](#fig1s1){ref-type="fig"}*), is the alpha-tubulin a cross reaction? If yes, why are microtubules not seen in immunostained cells (*[*Figure 1--figure supplement 1E*](#fig1s1){ref-type="fig"}*)? It should be explicitly mentioned that the Abs were validated by immunocytochemistry in transfected cells*.

We apologise for the confusion regarding the alpha-Tubulin staining. The membrane was first probed with anti-Fltp antibodies, developed and subsequently with anti-alpha Tubulin antibodies to confirm equal loading. We state this in the new Figure legend ([Figure 1--figure supplement 1A](#fig1s1){ref-type="fig"}) and added that the antibodies were validated by immunocytochemistry in transfected cells to the manuscript.

Changes:

"We confirmed the specificity of these antibodies in Western blot analysis and immunocytochemistry ([Figure 1--figure supplement 1A-G, 2D](#fig1s1 fig1s2){ref-type="fig"})."

To:

"We confirmed the specificity of these antibodies in Western blot analysis and immunocytochemistry in transiently transfected HEK293T cells ([Figure 1--figure supplement 1A-G, 2D](#fig1s1 fig1s2){ref-type="fig"})."

"Anti-alpha-Tubulin antibody was subsequently used on the same blot to confirm equal loading."

*c)* [*Figure 2--figure supplement 1 F-I\'*](#fig2s1){ref-type="fig"} *and associated text: I cannot see endogenous Fltp green localization in monocilia. Could the figures be improved?*

We improved the quality and magnified endogenous Fltp cilia staining on monociliated node cells and multiciliated lung cells in [Figures 2G and 2H'](#fig2){ref-type="fig"}.

*d)* [*Figure 4*](#fig4){ref-type="fig"} *and associated text: This requires better explanations and/or illustrations. The text and legend do not allow the reader to understand* [*Figure 4E*](#fig4){ref-type="fig"}*. Similarly, it is not very clear that Fltp localizes along the length of cilia (B,B\'). This being said, the defective docking of BB in culture is very convincing, more than what is described in vivo in* [*Figure 3*](#fig3){ref-type="fig"}*. How can this be explained?*

We are sorry for the inadequate description of [Figure 4E](#fig4){ref-type="fig"}. We have added an illustration ([Figure 4A](#fig4){ref-type="fig"}) and a better explanation in the text.

Briefly, this figure describes how Fltp-H2B-Venus reporter expression is activated upon the differentiation of lung progenitor cells into multiciliated cells. Different stages (I-IV) can be used to categorise the chronologic events during ALI culture differentiation ([@bib44]). There is a clear correlation between Fltp-H2B-Venus reporter expression and amplification of BBs, the first visible step of progenitor differentiation to MCCs ([Figure 4A-B](#fig4){ref-type="fig"}). We changed the text in the following way:"Upon switch to ALI culture, lung progenitor cells (stage I) differentiate into multiciliated epithelial cells by passing through stages of centrosome/BB amplification, BB docking (stage II-III) and cilia formation (stage IV). Fltp-driven H2B-Venus reporter activity is activated during centrosomes/BB amplification and docking ([Figure 4E](#fig4){ref-type="fig"}), correlating with active PCP signaling and the onset of asymmetric localization of core components ([@bib42])."

To:

"Switching mTEC culture to ALI conditions induces a differentiation process of lung progenitor cells towards a MCC phenotype. During differentiation the progenitor cells pass through different maturation stages ([Figure 4A](#fig4){ref-type="fig"}): Monociliated lung progenitor cells (stage I) start centrosome/BB amplification followed by BB transport and docking (stage II-III) and subsequent cilia formation (stage IV) ([@bib44]). In these cultures, Fltp-driven H2B-Venus reporter activity is activated at the transition from stage I to stage II when centrosomes/BBs are amplified and docked in heterozygous and homozygous Fltp ALI cultures ([Figure 4B](#fig4){ref-type="fig"}). Fltp-H2B-Venus expression increases during maturation until cells are terminally differentiated. This correlates with active PCP signaling and initial asymmetric core component localization ([@bib42])."

"(A-G) LSM of ALI culture of FltpZV mTECs. (A-B') Single cell from the apical actin level (A, B) to the cilia level (A', B-B') (ALI day 9). Fltp connects to the apical actin, apical tyrosinated-Tubulin and localizes along cilia in multiciliated Fltp+/+ cells (A-A', B-B'). Fltp is localized at the apical TJ level (C) and co-localizes with BBs (D) (ALI day 4). (E) Onset and level of Fltp reporter expression correlates with onset of BB amplification and ciliogenesis in cultured ALI mTECs. Staging according to ([@bib44])."

To:

"(A) Scheme of multiciliated cell (MCC) maturation. A MCC progenitor projects a primary cilium at the apical surface (stage I). Centrosome amplification is the first sign of differentiation (stage II) followed by apical transport and docking of BBs (stage III). Fully differentiated cells project multiple motile cilia at the apical surface (stage IV). Staging according to ([@bib44]). The green nucleus indicates Fltp reporter gene expression. (B-G) LSM of ALI culture of FltpZV and WT mTECs. (B) Onset and level of Fltp reporter expression correlates with onset of BB amplification and ciliogenesis (stage II-IV) in cultured ALI mTECs as shown in the scheme in (A). (C-C''') Confocal sections of a single cell from the sub-apical actin level (C) over the apical actin level (C',C'') to the cilia level (C''') (ALI day 4). Fltp co-localizes with the MT-plus end binding protein EB-1 (D) (ALI day 4) next to the pericentriolar matrix (E) (ALI day 4) and to cilia in multiciliated Fltp+/+ cells (C''')."

We agree that Fltp localisation at the cilium is not perfect. We removed B and B'

*e) Inner ear,* [*Figure 5*](#fig5){ref-type="fig"}*. From 5C, I have the impression that PCP in IHC is even more disturbed than in OHC, and seems to be confirmed in the quantification N. However, Fltp is said to be expressed on in OHC. Does this mean that Fltp has some non-cell autonomous effects, or that low expression is present in IHC?*

In the legend of [Figure 5](#fig5){ref-type="fig"} we wrote that Fltp reporter expression is restricted to sensory HCs. This includes IHCs as well as OHCs. We changed this in the manuscript to make it clearer. Currently we have no reason to believe that Fltp might act non-cell autonomously.

Change:"Fltp reporter expression is restricted to sensory HCs of the OC (red dashed line)."

To:

"Fltp reporter expression is restricted to all sensory HCs (IHC and OHC) of the OC (red dashed line)."

*f) For quantification, authors mention ANOVA; it is probably acceptable for relatively small angles, less than 40*^*o*^ *in this series of data. Still, authors should be aware that comparison of angles is usually done using circular statistics, because arithmetic mean of angles is not meaningful*.

We thank the reviewer for pointing this out. In fact, we were not aware that a proper analysis should be done using circular statistics. Most angles are less than 40 degrees, but there are some exceptions. We hence repeated the testing procedure, this time using the tools of circular statistics. Our first approach was to replace the standard ANOVA (for two groups) by a Watson-Williams test. This is readily implemented in MATLAB and R. However, both implementations require equal group sizes. This was not given in our data. We hence simply performed a two-sided t-test. In the test statistic, we calculated the mean and the standard deviation according to circular statistics. The resulting p-values turned out to be even lower than in our original analysis. In fact, they often were below detection limit. Our results hence change such that all differences between wild types and homozygotes are significant. We implemented the new statistics in [Figure 5](#fig5){ref-type="fig"} N.

"Statistical analysis uses a one way ANOVA (\*\*\* P=0.0001; \*\*\*\* P\<0.0001). Error bars show the 95% confidence interval of the mean."

To:

"Statistical analysis uses circular statistics (\*\*\*\* P\<0.0001). Error bars show the standard deviation."

*g) The addition of phenotypes in Celsr1+Fltp mutants is interesting and worth showing. On the other hand, I do not think that this indicates that both proteins act in the same PCP pathway; they could just as well act in two parallel pathways. I think the text should be modified to take this into account*.

We agree with reviewer 1 and 2 that Celsr1 and Fltp could act in two parallel pathways. We changed this in the manuscript.

Changes:

"To directly test if Fltp functions in the PCP pathway, we investigated genetic interaction of Fltp with the core PCP component Celsr1 ([@bib5])."

To:

"To seek first evidence if Fltp functions in the PCP pathway,we investigated a potential genetic interaction of Fltp with the core PCP component Celsr1 ([@bib5])."

"This demonstrates that Fltp genetically interacts with the core PCP gene Celsr1 and acts in the PCP pathway."

To:

"These data suggest that Fltp and the core PCP gene Celsr1 either act together in the PCP pathway or in two parallel pathways important for the morphogenesis of the cochlea."

*I also do not understand why authors looked at the localization of Vangl1 rather than Vangl2; which has a stronger action in PCP - for which good Abs are available commercially*.

Thank you for the comment but we were not aware that good Vangl2 antibodies are available. To analyse PCP in lung MCCs and tracheal epithelium, [@bib42] used Vangl1 antibodies and could demonstrate nice asymmetric localisation. Fukuda et al. (2014) additionally showed asymmetric Vangl1 distribution in the inner ear. Based on these findings we used Vangl1 as a marker to show asymmetric core PCP protein distribution.

3\) Last part of Results and [Figure 7](#fig7){ref-type="fig"}.

*The subtitle and the following text are too strong. The data shown in* [*Figure 7*](#fig7){ref-type="fig"} *are really informative, yet colocalisation does indicate but no prove interaction. The change in localization upon inactivation of Fltp, illustrated in* [*Figure 8*](#fig8){ref-type="fig"}*, provide a stronger argument for interaction than simple colocalisation, and the Co-IP in HEK cells is also a strong indication. As authors know and although their data are strong, interactions should be demonstrated using techniques such as IP in vivo, or FRET and others. I agree that this is undoable given the reagents available. However, given this intrinsic limitation, strong claims are not acceptable and should be significantly tuned down*.

We changed the subtitle and tuned down the statements accordingly.

4\) As mentioned above, the Discussion, although scholarly and informative, is somewhat hyperbolic and should be more nuanced.

We partially rewrote the Discussion to tune down the overstated conclusions.

*I would also like to have the opinion of the authors on why the effect on cilia docking is present only in some cells, whereas Fltp seems to be a unique gene without paralog*.

This is a very interesting question for which we have no definitive answer. The most likely explanation is the presence of other genes with similar functions, such as the PCP effector molecules Intu and Fuz (see Discussion).

We have initially concentrated our analysis on the lung and inner ear. Closer inspection of other cell types might reveal additional phenotypes, e.g. multiciliated ependymal cells were not investigated. In very rare cases (\<1%) we observed an exencephalus phenotype indicative of a PCP-related phenotype. In Figure 1--figure supplement 3B Mendelian ration shows a slight underrepresentation of Fltp 129 KO animals, which we note in the figure legend. It is highly speculative, but left-right defects due to inappropriate ciliary position at the node might cause congenital heart defects. We will investigate this possibility in future experiments.

Reviewer \#2:

*The authors present data showing that Fltp has a function in localizing basal bodies in multiciliated airway cells and in cochlear hair cells. Fltp is expressed in many ciliated cells where the PCP pathway functions. In fltp mutant MCCs, BBs fail to dock, and in mutant cochlea, BB/kinocilia are mispositioned and stereocilia bundles are misoriented and distorted. Fltp localizes apically in both cell types. The authors also describe, using a mutant, a function for Dlg3 in orienting BB/kinocilia. Finally, they show that transfected Fltp and Dlg3 co-IP, and that gamma tubulin and Dvl2 are also pulled down. These data could perhaps make a reasonable story that Fltp is involved in BB positioning in several cell types. However, the manuscript is written in such a way to substantially over-interpret their data, and a number of important holes in the data exist. As an appropriately described piece of work, it would be an editorial decision as to whether the results merit publication in this journal*.

*The overreaching interpretation of the results is evident with regard to several points. The authors devote considerable discussion to how Fltp participates in linking tubulin and actin in these processes, based only on the localization data and the phenotype, without any ultrastructure or biochemistry to support these conclusions. This discussion should all be deleted from the main text, and relegated to speculation in the Discussion*.

We agree with the reviewer and toned down or deleted over-statements.

*A considerable omission is the failure to examine a potential role for Dlg3 in MCCs. Is there any MCC phenotype in the mutant? If not, how should one interpret the docking defect in comparison to the hair cell phenotype? This highlights the problem that there is not a strong parallel between BB docking in MCCs and BB positioning in hair cells*.

The aim of our study was not to compare BB docking in MCCs and BB/cilia positioning in inner ear hair cells, but rather to provide a description of the Fltp phenotype in the lung and inner ear. We focused more on cellular and molecular mechanism of Fltp function in the inner ear, as it is a well-described PCP model system (as stated in the new discussion). Due to the Fltp phenotype in BB positioning, we focused in this system on Dlg3, as Drosophila Dlg is a well-known spindle positioning protein.

For this reviewer we examined a potential role of Dlg3 in MCCs. We analysed lungs of Dlg3 KO animals and could not detect an obvious difference in BB docking or cilia formation between KOs and WT animals (n=2). This indicates that Dlg3 and Fltp cooperate in the inner ear to position BB/cilia and other Dlg family members might compensate for Dlg3 loss-of-function in the lung MCCs. We provide this information for the reviewer only, because this goes beyond the scope of our manuscript.Author response image 3.(A-B) Show cryosections of a WT lung stained with acetylated tubulin (red) and pericentrin (green) and DAPI (blue). BBs are docked and cilia formed. (C-D) Cryosections of a Dlg3 KO animal show docked BBs and cilia. Scale bars: (A,C) 7μm, (B,D) 2μm.

*A third substantial and related problem is that the model is very unclear. The cartoon suggests that Fltp localizes to stereocilia, but the binding data suggest it should be found with gamma tubulin at the BBs*.

We apologise and removed the model from the figure set.

Finally, the authors discuss function at the TJs.

We discuss Dlg3 function at the TJ in the context of the IE ([Figure 7](#fig7){ref-type="fig"}), because Dlg3 was shown to localise to apical TJs and interact with TJ-associated proteins ([@bib41]; Dev Cell).

*Since MCCs don\'t have the equivalent of stereocilia, where is the commonality? In these cells, Fltp is seen in the apical meshwork, but the resolution is too low to make specific conclusions about exactly where. We know too little to extract any inference about commonality of Fltp function from the two cell types*.

We now provide higher quality pictures of the localization of Fltp in the apical meshwork ([Figure 4](#fig4){ref-type="fig"}). As stated above, we do not intend to extract commonality of Fltp function in mono- and multiciliated cell types. However, the obvious commonality is the localization and close association of Fltp with the apical actin and MT cytoskeleton, the BB(s) and cilia (compare [Figure 4 and 7](#fig4 fig7){ref-type="fig"}) and the function in BB docking and positioning (compare [Figure 4, 5 and 8](#fig4 fig5 fig8){ref-type="fig"}).

*There is one very troubling piece of data that must be explained, and unsatisfactory resolution will invalidate the MCC findings. The IMARIS resonstructions in* [*Figure 4*](#fig4){ref-type="fig"} *HI show mostly docked vs many undocked BBs, but it is normally easy to find cells in day 4 cultures with undocked BBs, as cells continue to differentiate for some time*.

We agree with the reviewers comment that in day 4 cultures cells with undocked BBs can be found. This is exactly what we observed, except that Fltp homozygous cultures always show a reduced number of docked BBs compared to WT cultures.

*Care must be taken that these are representative. Therefore the quantitative data are essential. The MTEC data from day 2 and day 4 shown in* [*Figure 4-figure supplement 1*](#fig4s1){ref-type="fig"} *are at best, extremely confusing, and at worst, suggest the possibility that the results should be discarded. First, it is unclear what the authors are measuring. The number of BBs? The number or percent of docked BBs? Number of cells with docked BBs? This must be made clear*.

We apologize for the bad representation of our data; we measured number of cells with docked BBs (amount of docked BBs was categorized in different percentage groups). As this is too complicated we simplified the quantification and took care that we analysed representatives.

ALI cultures do not always differentiate with same rate and efficiency. To normalize for variability in differentiation we only compared WT and HOM cultures when they differentiated to a comparable extend ([Figure 4--figure supplement 1A](#fig4s1){ref-type="fig"}). The percentage of differentiating MCCs; according to GFP/pericentrin staining among all cells analysed is shown.

Next, we examined BB docking by staging the differentiating cells into stage II-III (BB amplification and docking) and stage IV (every BB has a cilia and is docked) (see model [Figure 4A](#fig4){ref-type="fig"}). This revealed at day 2 and day 4 BB docking defects in Fltp knock-out cultures, when compared to WT ([Figure 4--figure supplement 1B](#fig4s1){ref-type="fig"}).

Representative images and how we quantified these are shown below:Author response image 4.(A-A'') WT cultures at day 0, ALI day 2 and ALI day 4. In day 0 cultures MCCs are already present (A). Day 2 and day 4 ALIs show mostly 100% docked BBs (red, pericentrin; white, cilia) (A',A''). (B-B'') In HOM cultures at day 0 some cells are already multiciliated but not to the same extend as WT cultures. At day 2 most stage II-III cells do not have docked their BBs yet. Significantly more BBs are docked in WT cultures (A'-A'') than in HOM cultures (B'-B''). Light white staining marks the intracellular MT network. Only bright white staining marks cilia.Scale bars; (A,B) 5μm; (A',A'') 25μm; (B',B'') 30μm.

*Furthermore, in this highly reproducible system, at ALI+2 days, there are only very few cells with multiple cilia, yet the authors\' data seem to suggest that 80% of the cells are multiciliated (to completion??). In the best wildtype cultures, 80% of cells are never seen to become multiciliated*.

We only analysed cells differentiating into MCCs and excluded non-differentiating cells present in the ALI culture. The overall percentage of cells that started differentiating according to anti-GFP and anti-Pericentrin staining can be seen in the new [Figure 4--figure supplement 1A](#fig4s1){ref-type="fig"} (max. 22%). We categorized these cells into cells in stage II-III (BB amplification and docking) and stage IV (every BB has a cilia and is docked) in [Figure 4--figure supplement 1B](#fig4s1){ref-type="fig"}.

Additionally, we analysed mTECs at ALI day 0 (directly before switching) and day 1. We could show that MCCs are already present before switching to ALI conditions. We propose that cells which are already multiciliated at day 0 develop to fully mature stage IV MCCs by day 2 accounting for this high amount of stage IV cells at day 2 ([Figure 4--figure supplement 1B](#fig4s1){ref-type="fig"}).

*Furthermore, by day 4, the number has declined to 60%? Why? At this stage, the numbers should still be increasing. In light of this, how are we to interpret the mutant results? We need a description of what is being measured, as well as images to corroborate*.

This is a very good question for which we do not have a definitive answer. MCCs are already present at day 0 and 1. From day 0 to day 2 the amount of stage II-IV cells increases from approx. 5% to 18%. We hypothesize that this rapid increase in stage II-IV cells is due to the presence of MCCs before the switch to ALI conditions. These cells might also more efficiently show BB docking and cilia formation. Additionally, new stage I cells are entering the differentiation process after switch to ALI conditions. The amount of these cells increases and potentially reduce the number of docked stage IV cells at day 4. To definitively proof this hypothesis, we would need to do live cell analysis, which is beyond the scope of this work. The number of differentiating cells are still increasing.

*Another problem is with the "genetic interaction" between fltp and celsr1. Genetic interaction is typically shown between heterozygotes that have no phenotype on their own, or between one het with no phenotype and a homozygote with a weak phenotype. The authors make double homozygous mutants and show an enhanced phenotype. Yet each homozygote has a phenotype of its own, and therefore the result could simply be an additive phenotype. The result therefore DOES NOT show a genetic interaction and provides NO EVIDENCE that Fltp is in the PCP pathway. The result is equally consistent with distinct pathways converging on a shared output*.

We totally agree with the comment that Celsr1+Fltp could also act in two parallel pathways and we added this to the manuscript.

*Numerous other statements describing Fltp function in PCP signaling are also misleading. For example, describing Dvl2 function at BBs as a PCP function is not valid. Indeed, the MCC phenotype is not a PCP phenotype at all, and the hair cell phenotype impacts PCP, but is presumably quite downstream. Taken together, it is not reasonable to describe the results as being effectors of PCP. This is another big example of interpretation not correctly reflecting the findings*.

We agree and have toned down the statements as outlined above for reviewer 1.

Reviewer \#3:

*1) Many references are made to "Detailed" subcellular co-localization studies. But these data are not at all clear in their current form. In particular the data in* [*Figure 3*](#fig3){ref-type="fig"} *are over-interpreted. It is stated that Fltp "specifically" colocalizes with newly synthesized MT plus-ends, but* [*Figure 3B*](#fig3){ref-type="fig"} *shows much green where there is no red and much of the converse as well*.

We agree and apologise for the bad quality of [Figure 4](#fig4){ref-type="fig"}. We changed several panels and added a co-staining of Fltp and EB-1.

*2) The claim is made in* [*Figure 3*](#fig3){ref-type="fig"} *that fltp is localized to the apical but not the sub-apical actin in multiciliated cells, yet* [*Figure 3A*](#fig3){ref-type="fig"} *shows only a single x/y image and* [*Figure 3c*](#fig3){ref-type="fig"} *shows Zo1, but not actin. How is this claim justifiable from these data?*

We replaced [Figure 4A](#fig4){ref-type="fig"} and show now a Z stack which shows that Fltp is not localized to the subapical actin network ([Figure 4C](#fig4){ref-type="fig"}), but to the apical actin cytoskeleton ([Figure 4C'-C''](#fig4){ref-type="fig"}), cilia ([Figure 4C'''](#fig4){ref-type="fig"}), MT plus ends ([Figure 4D](#fig4){ref-type="fig"}) and around the pericentriolar matrix ([Figure 4E](#fig4){ref-type="fig"}).

*3) The authors need to comment on the possible role for fltp in basal body amplification. According to* [*Figure 5*](#fig5){ref-type="fig"}*, the most obvious phenotype in the mutants may not be BB docking, but the reduction in BB numbers. This issue is a big one because recent work on cyclin O from Kinter and Omran shows that BB docking and amplification may be linked*.

Thank you for the valuable comment. This is an interesting point but the phenotype observed is a clear BB docking phenotype. We reanalysed the data and have not noticed cells with significant less centrosomes in Fltp KO ALI cultures compared to WT ALIs (also compare [Figure 4F and 4G](#fig4){ref-type="fig"}).
